<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7824868</article-id><article-id pub-id-type="pmid">33466408</article-id><article-id pub-id-type="doi">10.3390/nu13010154</article-id><article-id pub-id-type="publisher-id">nutrients-13-00154</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9446-4046</contrib-id><name><surname>Park</surname><given-names>Seung-Hyeok</given-names></name><xref ref-type="aff" rid="af1-nutrients-13-00154">1</xref><xref ref-type="author-notes" rid="fn1-nutrients-13-00154">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Minsun</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00154">2</xref><xref ref-type="author-notes" rid="fn1-nutrients-13-00154">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Somi</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00154">2</xref></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Woojin</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00154">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8678-156X</contrib-id><name><surname>Kim</surname><given-names>Bonglee</given-names></name><xref ref-type="aff" rid="af2-nutrients-13-00154">2</xref><xref ref-type="aff" rid="af3-nutrients-13-00154">3</xref><xref rid="c1-nutrients-13-00154" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-13-00154"><label>1</label>Department of Korean Obstetrics &#x00026; Gynecology, Kyung Hee University Korean Medicine Hospital, Seoul 02447, Korea; <email>baomose@khu.ac.kr</email></aff><aff id="af2-nutrients-13-00154"><label>2</label>College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea; <email>red_pomme@khu.ac.kr</email> (M.K.); <email>mayleee0110@khu.ac.kr</email> (S.L.); <email>wj0119@khu.ac.kr</email> (W.J.)</aff><aff id="af3-nutrients-13-00154"><label>3</label>Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea</aff><author-notes><corresp id="c1-nutrients-13-00154"><label>*</label>Correspondence: <email>bongleekim@khu.ac.kr</email>; Tel.: +82-2-961-9217</corresp><fn id="fn1-nutrients-13-00154"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>13</volume><issue>1</issue><elocation-id>154</elocation-id><history><date date-type="received"><day>24</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cervical cancer is the fourth most common cancer among women worldwide. Though several natural products have been reported regarding their efficacies against cervical cancer, there has been no review article that categorized them according to their anti-cancer mechanisms. In this study, anti-cancerous natural products against cervical cancer were collected using Pubmed (including Medline) and google scholar, published within three years. Their mechanisms were categorized as induction of apoptosis, inhibition of angiogenesis, inhibition of metastasis, reduction of resistance, and regulation of miRNAs. A total of 64 natural products suppressed cervical cancer. Among them, <italic>Penicillium sclerotiorum</italic> extracts from <italic>Cassia fistula</italic> L., ethanol extracts from <italic>Bauhinia variegate candida</italic>, thymoquinone obtained from <italic>Nigella sativa</italic>, lipid-soluble extracts of <italic>Pinellia pedatisecta</italic> Schott., and 1&#x02032;S-1&#x02032;-acetoxychavicol extracted from <italic>Alpinia conchigera</italic> have been shown to have multi-effects against cervical cancer. In conclusion, natural products could be attractive candidates for novel anti-cancer drugs.</p></abstract><kwd-group><kwd>cervical cancer</kwd><kwd>dietary natural products</kwd><kwd>apoptosis</kwd><kwd>angiogenesis</kwd><kwd>metastasis</kwd><kwd>resistance</kwd><kwd>microRNA</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-13-00154"><title>1. Introduction</title><p>Cervical cancer, which is a cancer arising from the cervix, is characterized by abnormal vaginal bleeding, vaginal discharge, pelvic pain, or pain during sexual intercourse [<xref rid="B1-nutrients-13-00154" ref-type="bibr">1</xref>]. Currently, cervical cancer is the fourth most common cancer among women in the world [<xref rid="B2-nutrients-13-00154" ref-type="bibr">2</xref>]. According to Globocan 2018, the prevalence rate of cervical cancer is 3.2% of all cancers. The main treatments for cervical cancer are surgery such as pelvic lymphadenectomy and radical hysterectomy, radiotherapy, and chemotherapy [<xref rid="B3-nutrients-13-00154" ref-type="bibr">3</xref>]. Another therapy is targeted therapy, which regulates epidermal growth factor receptor (EGFR) [<xref rid="B4-nutrients-13-00154" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-13-00154" ref-type="bibr">5</xref>] and cyclooxygenase-2 (COX-2) [<xref rid="B6-nutrients-13-00154" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-13-00154" ref-type="bibr">7</xref>] for treating cervical carcinoma. However, these treatments showed possible side effects and complications: Surgery could cause bleeding, damage to the organs around the surgery, and a risk of clots in the deep veins of the legs, radiotherapy could yield menopause, infertility, discomfort, or pain with intercourse, and the side effects of chemotherapy may affect not only cancer cells but also rapidly dividing cells in systems of the whole body [<xref rid="B8-nutrients-13-00154" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-13-00154" ref-type="bibr">9</xref>]. Moreover, the drugs that are usually prescribed for cervical cancer showed several side effects and drug resistance [<xref rid="B10-nutrients-13-00154" ref-type="bibr">10</xref>]. Cisplatin, which is one of the most effective anticancer drugs, has resistance capacity by a self-defense mechanism [<xref rid="B11-nutrients-13-00154" ref-type="bibr">11</xref>]. 5-fluorouracil (5-FU) is also reported for resistance and side effects when it comes to cervical cancer patients [<xref rid="B12-nutrients-13-00154" ref-type="bibr">12</xref>]. Thus, we have focused on discovering a new potent treatment for cervical cancer from natural products.</p><p>Natural products extracted from living organisms including plants and animals have several active ingredients, which are reported to be attractive alternatives to chemotherapeutic drugs or suitable for combined use with chemotherapeutic drugs [<xref rid="B13-nutrients-13-00154" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-13-00154" ref-type="bibr">14</xref>]. For example, purified flaxseed hydrolysate (PFH), extracted from Lignan, induces apoptosis and inhibits angiogenesis and metastasis on HeLa cells [<xref rid="B15-nutrients-13-00154" ref-type="bibr">15</xref>]. Thymoquinone from <italic>Nigella sativa</italic> also showed apoptotic effect and anti-proliferation in SiHa and CaSki cells. Such natural products include <italic>Bauhinia variegate candida</italic> ethanol extracts, Praeruptorin-B, and well-known tea.</p><p>MicroRNA (miRNA, miR) are involved in the pathological development and metastasis of cancer [<xref rid="B16-nutrients-13-00154" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-13-00154" ref-type="bibr">17</xref>]. Several natural products showed an anti-cancer effect by regulation of cancer-related miRNAs. Our team reported that <italic>Spatholobus suberectus</italic> Dunn extract induces apoptosis by regulation of miR-657/activating transcription factor 2 (ATF2) in U266, U937 cells [<xref rid="B18-nutrients-13-00154" ref-type="bibr">18</xref>]. Another natural product, <italic>Salvia miltiorrhiza</italic>, showed an anti-cancer effect via regulation of miR-216b [<xref rid="B19-nutrients-13-00154" ref-type="bibr">19</xref>]. 1&#x02032;S-1&#x02032;-acetoxychavicol acetate (ACA) from <italic>Alpinia conchigera</italic> has been reported to induce apoptosis on SiHa and CaSki cells by targeting SMAD4 and miR-210. Targeting miRNAs with natural products could be a promising strategy for cervical cancer [<xref rid="B20-nutrients-13-00154" ref-type="bibr">20</xref>]. However, there have been no studies that organize the mechanisms, efficacy, and concentration of natural products for cervical cancer in last five years. In this present study, we aim to review the nonclinical studies about the anti-cancer mechanisms of natural products. The natural products were organized by their mechanisms including apoptosis, anti-metastasis, anti-angiogenesis, resistance, and microRNA regulation.</p></sec><sec sec-type="methods" id="sec2-nutrients-13-00154"><title>2. Methods</title><p>We collected the relevant experimental literature published in recent three years elucidating the anticancer effects of natural products on cervical cancer using PUBMED (including Medline) and the Google Scholar database. Upon searching for the appropriate studies, we used &#x02018;natural product, cervical cancer&#x02019; as keywords. After completing the initial search, we removed duplicates and non-English literature. Chemical structures of compounds derived from natural products were cited from the NCBI PubChem website.</p></sec><sec sec-type="results" id="sec3-nutrients-13-00154"><title>3. Results</title><sec id="sec3dot1-nutrients-13-00154"><title>3.1. Apoptosis</title><p>Apoptosis is a unique form of cell death and is an important process that regulates the homeostasis of cell survival [<xref rid="B21-nutrients-13-00154" ref-type="bibr">21</xref>]. Apoptosis eliminates potentially cancerous cells and this process is caused by atrophy of cells, synthesis of new proteins, and cell suicide genes; also, it has a great influence on the malignant phenotype [<xref rid="B22-nutrients-13-00154" ref-type="bibr">22</xref>]. For this reason, apoptosis is used as an anticancer mechanism for cancer research. A total of 47 studies have been performed to elucidate apoptosis-mediated anti-cancer pathway of natural products in Hela and SiHa cells. A total of 54 natural products were reviewed.</p><sec id="sec3dot1dot1-nutrients-13-00154"><title>3.1.1. Compounds</title><p>Among the natural products, 35 compounds showed an apoptotic effect against cervical cancer (<xref rid="nutrients-13-00154-t001" ref-type="table">Table 1</xref>). The chemical structures of the compounds are shown in <xref ref-type="fig" rid="nutrients-13-00154-f001">Figure 1</xref>.</p><p>Li et al. showed that 4w of DHA-Based acylhydrazones induces anti-cancer activity with an IC<sub>50</sub> value of 2.21 &#x000b5;M for 48 h in Hela cells [<xref rid="B23-nutrients-13-00154" ref-type="bibr">23</xref>]. Interestingly, 4w was about 17-fold more active than that of the parent compounds. Vishnu et al. reported that anthocyanins, extracted from purple root tubers and leaves of <italic>Ipomoea batatas</italic>, was shown to promote CFP/YFP activity in HeLa cells [<xref rid="B24-nutrients-13-00154" ref-type="bibr">24</xref>]. The treatment was done at concentrations of 100 and 200 &#x000b5;g/mL for 48 h. The result showed the induction of apoptosis, cell cycle arrest, and alteration of cell morphology by the treatment. Moreover, the leaf anthocyanins exhibited significantly higher activity against cervical cancer cells. Arborinine isolated from <italic>Glycosmis parva</italic> upregulated caspase-3, -7, and downregulated Bcl2-L1 at a dose of 110 &#x003bc;g/mL for an incubation time of 24 h in HeLa cells [<xref rid="B25-nutrients-13-00154" ref-type="bibr">25</xref>]. This result suggested that induction of apoptosis and inhibition of migration were involved in anti-cancer effect of arborinine. Arborinine also inhibited tumor spheroid growth than chemotherapeutic drugs such as bleomycin, gemcitabine, and cisplatin. Expression of p15, p53, and Bax were increased and cyclin D1, Bcl-2, MMP-2, -9, &#x003b2;-catenin, TCF7, and c-Myc were decreased by treatment of &#x003b2;-elemene extracted from <italic>Curcuma zedoaria</italic> in SiHa cells at dose of 30 &#x003bc;g/mL, 40 &#x003bc;g/mL, and 50 &#x003bc;g/mL for 24 h, 48 h, and 72 h [<xref rid="B26-nutrients-13-00154" ref-type="bibr">26</xref>]. This result suggested that induction of cell cycle arrest and inhibition of migration are involved in the pathway. In addition, &#x003b2;-elemene inhibited cell proliferation and invasion and induced apoptosis via attenuation of the Wnt/&#x003b2;-catenin signaling pathway in cervical cancer cells. Copper oxide nanoparticles synthesized by <italic>Azadirachta indica</italic>, <italic>Hibiscus rosasinensis</italic>, <italic>Murraya koenigii</italic>, <italic>Moringa oleifera</italic>, and <italic>Tamarindus indica</italic> induced apoptosis and inhibited oxidant in HeLa cells at doses of 2 &#x003bc;g/mL, 5 &#x003bc;g/mL, 10 &#x003bc;g/mL, 25 &#x003bc;g/mL, 50 &#x003bc;g/mL, and 100 &#x003bc;g/mL for 48 h [<xref rid="B27-nutrients-13-00154" ref-type="bibr">27</xref>]. Expression of p53, cytochrome c, caspase-3, -7, -9, and PARP were increased and Bcl-2 and NF-&#x003ba;B were decreased in HeLa cells by treatment of curcumin-loaded TPGS/F127/P123 mixed polymeric micelles isolated from <italic>Curcuma longa</italic> at dose of 2 &#x003bc;g/mL for 48 h [<xref rid="B28-nutrients-13-00154" ref-type="bibr">28</xref>]. Through the mechanisms, this induced apoptosis, mitochondria-mediated apoptosis, and cell cycle arrest. In vivo, mice were provided 25 mg/kg 11 times in 2-day intervals and in the curcumin-loaded TPGS/F127/P123 group, this could efficiently inhibit the growth of cervical cancer cells. Emodin reduced activation of HOCl/OCl- and p-Akt and inhibited NO- and O2- at concentrations of 46.3 &#x003bc;g/mL, 92.8 &#x003bc;g/mL, and 185 &#x003bc;g/mL for 6 h, 12 h, and 24 h for the treatment of SiHa and C33A cells [<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]. The result showed that emodin was related to induction of cell cytotoxicity, apoptosis, oxidative stress, and DNA damage. When HeLa cells were treated by epifriedelinol isolated from <italic>Aster tataricus</italic> and <italic>Vitex peduncularis</italic>, the level of caspase-3, -8, and -9 were increased and Bcl-2, -xL, survivin, and actin were decreased at doses of 50 &#x003bc;g/mL, 100 &#x003bc;g/mL, 250 &#x003bc;g/mL, 500 &#x003bc;g/mL, and 1000 &#x003bc;g/mL for 72 h [<xref rid="B30-nutrients-13-00154" ref-type="bibr">30</xref>]. Through the mechanisms, it reduced cell viability and induced apoptosis by downregulating the expression of anti-apoptotic protein and enhancing the expressions of pro-apoptotic protein. In addition, it altered the ratio of pro-apoptotic to anti-apoptotic proteins. Eugenol from <italic>Syzygium aromaticum</italic> was treated to HeLa cells at doses of 12.5 &#x000b5;M and 25 &#x000b5;M for 24 and 48 h [<xref rid="B31-nutrients-13-00154" ref-type="bibr">31</xref>]. The treatment upregulated Bax, PARP, caspase-3, and ROS and downregulated both Bcl-2 and XIAP in HeLa and SiHa cells. The result showed the inhibitory efficacy of eugenol by changing the cell viability in a time- and dose-dependent manner with consistent morphological changes. In the study of Chen et al., the treatment of icaritin, which derived from <italic>Epimedium</italic>, increased ROS, Bax, c-caspase-3, and -9 and decreased Bcl-2 and XIAP in both HeLa and SiHa cells [<xref rid="B32-nutrients-13-00154" ref-type="bibr">32</xref>]. In the treatment, HeLa cells were treated at concentrations of 12.5 &#x000b5;M and 25 &#x000b5;M for 24 h, 48 h, and 72 h, and SiHa cells were treated at 12.5 &#x000b5;M and 25 &#x000b5;M for 24 h, 48 h, and 72 h. This result indicated that icaritin promoted cancer cell death via induction of extensive oxidative DNA damage, which subsequently resulted in large numbers of DNA strand breaks and the activation of the intrinsic apoptotic pathway. Kuo et al. reported the efficacy of juncusol, which originates from <italic>Juncus inflexu</italic>, against HeLa, SiHa, and CaSki cells [<xref rid="B33-nutrients-13-00154" ref-type="bibr">33</xref>]. With concentrations of 1 &#x000b5;M, 3 &#x000b5;M, 10 &#x000b5;M, and 30 &#x000b5;M for 24 h, 48 h, and 72 h, the treatment induced cell apoptosis and inhibited cell proliferation. Cell cycle analysis showed an increase in G2/M and sub G1 cell populations after juncusol treatment. Furthermore, caspase-3, -8, and -9 were observed to be activated in HeLa cells, suggesting that the treatment induced apoptosis. Moreover, juncusol inhibited tubulin polymerization, as well as EGFR activation, this might suggest that juncusol induced a G2/M-phase cell cycle arrest and inhibited cell migration. Ma et al. evaluated the anti-cancer activity of methyl protodioscin, isolated from <italic>Polygonatum sibiricum</italic>, which led to cell apoptosis in HeLa cells by increasing G2/M phase and ROS [<xref rid="B34-nutrients-13-00154" ref-type="bibr">34</xref>]. Methyl protodioscin was used at concentrations of 18.31 &#x000b5;M, 40 &#x000b5;M, and 49 &#x000b5;M for 24 h. This treatment had efficacy on inducing alteration of cell morphology and cell cycle arrest as well as inhibiting cell proliferation. Al-Otaibi et al. showed cytotoxicity and apoptosis enhancement in Hela cells by co-administration of mitomycin C (MMC) in ginger (Gi) and frankincense (Fr) oil [<xref rid="B35-nutrients-13-00154" ref-type="bibr">35</xref>]. When treated at a dose of 10 &#x000b5;g/mL for 24 h, Fr-MMC endured the nuclear apoptosis in HeLa cells at a lower concentration compared to Gi-MMC. Moreover, mixing MMC with Gi-NE and Fr-NE considerably improved its cytotoxicity on HeLa cells. Latif et al. observed antitumor activity of naringenin oxime and oxime ether derivatives [<xref rid="B36-nutrients-13-00154" ref-type="bibr">36</xref>]. By the compounds, HeLa cells were treated at concentration of 12 &#x000b5;M and 24 &#x000b5;M for 24 h, and SiHa cells were treated at doses of 18 &#x000b5;M, and 36 &#x000b5;M for 24 h. As a result, compound 6 was shown to have an apoptotic effect on HeLa and SiHa cells by activating caspase-3. Moreover, cell cycle analysis suggested that compound 6 caused an increase in the subG1 phase and induced apoptosis in HeLa and SiHa cells. Induction of caspase-3 and -7 and inhibition of aldolase A, alpha-enolase, pyruvate kinase, and glyceraldehyde 3-p-dehydrogenase in both HPV16 and SiHa cells were observed after the exposure of nitensidine B isolated from leaves of <italic>Pterogyne nitens</italic> Tul [<xref rid="B37-nutrients-13-00154" ref-type="bibr">37</xref>]. Cells were treated at doses of 30 &#x000b5;M, 60 &#x000b5;M, and 120 &#x000b5;M for 6 h, 12 h, and 24 h. The result of study suggested that nitensidine B had efficacy on inducing apoptosis and inhibiting glycolysis. Notoginsenoside R7 isolated from <italic>Panax notoginseng</italic> upregulated Bax, p-PTEN, and Akt and downregulated Bcl-2, -XL, caspase-3, -9, and raptor in HeLa cells at the densities of 5 &#x000b5;M, 10 &#x000b5;M, 20 &#x000b5;M, and 40 &#x003bc;M for 24 h, 36 h, and 48 h [<xref rid="B38-nutrients-13-00154" ref-type="bibr">38</xref>]. In vivo, tumor weight was reduced by approximately 28% and 52%, respectively in 5 mg/kg/day and 10 mg/kg/day treated mice compared with a control group. Through the mechanisms, it induced apoptosis and inhibited proliferation. In conclusion, notoginsenoside R7 could be used for the treatment of cervical cancer and other PI3K/PTEN/Akt/mTOR signaling-associated tumors. The exposure of osthole derived from <italic>Cnidiummonnieri</italic> (L.) Cusson on HeLa, SiHa, C-33A, and CaSki cells upregulated the level of Bax, c-caspase-3, -9 proteins, E-cadherin, and H2AX [<xref rid="B39-nutrients-13-00154" ref-type="bibr">39</xref>]. However, osthole downregulated of Bcl-2, MMP-2, -9, &#x003b2;-catenin, vimentin, N-cadherin, IKK&#x003b1;, p-IKK&#x003b1;, p65, p-p65, p50, and NF-&#x003ba;B. This mechanism was made by osthole at concentrations of 40 &#x000b5;M, 50 &#x000b5;M, 80 &#x000b5;M, 100 &#x000b5;M, 120 &#x000b5;M, 150 &#x000b5;M, 160 &#x000b5;M, 200 &#x000b5;M, and 240 &#x000b5;M for 24 h and 48 h. The result showed that osthole had an efficacy of inducing apoptosis, as well as inhibiting cell proliferation, cell viability, cell migration, and cell invasion. Physcion reduced activation of HOCl/OCl- and p-Akt at 43.8 &#x003bc;g/mL, 87.5 &#x003bc;g/mL, and 175 &#x003bc;g/mL for 6 h, 12 h, and 24 h for the treatment of SiHa and C33A cells [<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]. The result showed that physcion was related to the induction of cell cytotoxicity, apoptosis, oxidative stress, and DNA damage. Phyto-synthesis of silver nanoparticles (AgNPs) isolated from garlic, green tea, and turmeric reduced cell viability and induced apoptosis and inhibited oxidant in HeLa cells [<xref rid="B40-nutrients-13-00154" ref-type="bibr">40</xref>]. Expression of free radicals was decreased through the treatment of AgNPs at doses of 2 &#x003bc;g/mL, 5 &#x003bc;g/mL, 10 &#x003bc;g/mL, 25 &#x003bc;g/mL, 50 &#x003bc;g/mL, and 100 &#x003bc;g/mL for 48 h. The AgNPs from turmeric extracts were the most excellent antioxidant and had great cytotoxicity activity compared to that synthesized using other extracts. Combination of paclitaxel and piperine, extracted from the plant <italic>Piper nigrum</italic>, was shown to promote the level of Bax, Bcl-2, c-PARP, and caspase-3 [<xref rid="B41-nutrients-13-00154" ref-type="bibr">41</xref>]. Additionally, the treatment decreased p-Akt and Mcl-1 in both HeLa and PTX cell. Cells were treated at a concentration of 50 &#x000b5;M for 6 h, 24 h, and 72 h. The result suggested induction of apoptosis was involved in the pathway. Zhang et al. reported that Hela cells showed increased EGFP, ROS, Bcl-2, cytochrome c, Apaf-1, caspase-3, and -9 and decreased c-Myc and hTERT after treated by prenylflavonoid C1 and C5, which derived from <italic>Mallotus conspurcatus</italic> [<xref rid="B42-nutrients-13-00154" ref-type="bibr">42</xref>]. These mechanisms were made at a concentration of 30 &#x003bc;M, for 24 h. The result indicated that the treatment was associated with induction of mitochondrial dysfunction, cytotoxicity, and apoptosis as well as inhibition of telomerase activity. Expression of JNK, p38, PERK, ATF4, Bax, caspase-3, -8, -9, and PARP were increased and Bcl-2 was decreased by treatment of protodioscin isolated from <italic>Dioscoreae rhizome</italic> in HeLa cells and C33A at the density of 4 &#x003bc;M for 24 h and 48 h [<xref rid="B43-nutrients-13-00154" ref-type="bibr">43</xref>]. Moreover, protodioscin was proved to induce ROS and the ER stress pathway. Consequently, protodioscin induced ER stress-dependent apoptosis, which could be mediated by the activation of the JNK and p38 pathways and mitochondrial dysfunction in the pathway. Chatterjee et al. showed the efficacy of two polyphenols, resveratrol and pterostilbene, against human HeLa cells [<xref rid="B44-nutrients-13-00154" ref-type="bibr">44</xref>]. Expression of activated caspase-3 was upregulated and PCNA and VEGF were downregulated in both PC1 and HPV E6 cells, at a concentration of 30 &#x000b5;M for 48 h. Further in vivo studies on TC1 tumors developing in mice indicated that treatment with either resveratrol or pterostilbene could significantly inhibit tumor development, with 1 mM for five days. This result suggested that resveratrol and pterostilbene induced cell cycle arrest and inhibited tumor growth in cervical cancer cell lines. Chen et al. reported that Tf-CT-ME, isolated from the plant <italic>Tripterygium wilfordii</italic>, upregulated c-caspase-3 and downregulated Bcl-2/Bax in HeLa cells [<xref rid="B45-nutrients-13-00154" ref-type="bibr">45</xref>]. The mechanisms were made by the treatment to HeLa cells, at doses of 0.5 &#x000b5;g/mL, 1 &#x000b5;g/mL, and 2 &#x000b5;g/mL for 24 h. This result meant that Tf-CT-ME induced cell cycle arrest and anti-proliferation. Thymoquinone isolated from <italic>Nigella sativa</italic> upregulated Bax and E-cadherin and downregulated Bcl-2, Twist1, and vimentin in SiHa and CaSki cells at doses of 10 &#x003bc;M, 20 &#x003bc;M, and 40 &#x003bc;M for 24 h, 36 h, and 48 h [<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]. The expression of PARP, caspase-3, -9, Bax, and Bcl-2 in CaSki and SiHa cells were nearly unaffected by thymoquinone. It suggested thymoquinone effected on human cervical cells by other mechanisms. Consequently, inhibition of invasion and growth, probably via Twist1/E-cadherin/EMT or/and Zeb1/E-cadherin/EMT, and induction of apoptosis were involved in the process. Triphala was a combination of the fruity part of <italic>Terminalia chebula</italic> Retz., <italic>Terminalia bellerica</italic> Roxb., <italic>Phyllanthus emblica</italic> Linn., and it was shown to inhibit proliferation and induct apoptosis in HeLa cells [<xref rid="B47-nutrients-13-00154" ref-type="bibr">47</xref>]. The IC<sub>50</sub> value against HeLa cells was 95.56 &#x000b1; 8.94 &#x003bc;g/mL. This process was made by increasing ERK and p53 and decreasing c-Myc, cyclin D1, p-Akt, p-NF-&#x003ba;B, p56, p-p44/42, and MAPK at a dose of 25 &#x003bc;g/mL for 48 h. In conclusion, triphala had great promise for treating cervical cancers. The level of RSU1 and GAPDH were increased in CaSki and SiHa cells by treatment of 1&#x02032;S&#x02019;-1&#x02032;-acetoxychavicol acetate (ACA) isolated from <italic>Alpinia conchigera</italic> at doses of 20 &#x003bc;M and 30 &#x003bc;M for 6 h, 12 h, and 48 h [<xref rid="B48-nutrients-13-00154" ref-type="bibr">48</xref>]. This result suggested that induction of apoptosis and reduction of cell viability were involved in the pathway. Downregulation of miR-629 enhanced sensitivity toward ACA and it indicated miR-629 could also play a role in regulating response toward anticancer agents. 2D and 3O of oleanolic acid and glycyrrhetinic acid derived from <italic>Ligustri Lucidi Fructus</italic> and <italic>Glycyrrhiza uralensis</italic> elevated the level of ROS in a concentration and time-dependent manner in HeLa cells [<xref rid="B49-nutrients-13-00154" ref-type="bibr">49</xref>]. 3O presented the strongest cytotoxicity on HeLa cells among the compounds. 2D was used at doses of 2 &#x000b5;M and 4 &#x000b5;M for 24 and 48 h, and 3O was used at 1 &#x000b5;M and 2 &#x003bc;M, for 48 h. Both compounds had an efficacy on inducing cell apoptosis, autophagy, alteration of cell morphology and cytotoxicity, and inhibiting proliferation. Hassan et al. reported that 4f, the compound of 3,5,4&#x02032;-trimethoxystilbene and 5,6,7-trimethoxyflavone, activated cytotoxic and apoptotic activity in HeLa cells [<xref rid="B50-nutrients-13-00154" ref-type="bibr">50</xref>]. There were morphological changes of the nuclei in HeLa cells at a dose of 10 &#x000b5;M, after 48 h. In addition, time- and dose-dependently increased fluorescence signal meant that cell death was triggered in proportion. In conclusion, the study showed that the compound 4f triggered cell death through induction of apoptosis in HeLa cells. 5&#x02032;-<italic>epi</italic>-SPA-6952A derived from <italic>Streptomyces diastatochromogenes</italic> upregulated the activation of Bax/Bcl-2, cytochrome c, caspase-3, -9, c-PARP, and p53, and downregulated MMP [<xref rid="B51-nutrients-13-00154" ref-type="bibr">51</xref>]. The mechanisms were observed at concentrations of 2 &#x000b5;g/mL, 4 &#x000b5;g/mL, 8 &#x000b5;g/mL, and 16 &#x000b5;g/mL, for 24 h. The treatment showed induction of apoptosis, cell cycle arrest, and alteration of cell morphology as well as inhibition of proliferation and migration.</p><p>Al-Otaibi et al. investigated the anticancer efficacy in HeLa cells upon co-administration of MMC and Gi and Fr oils [<xref rid="B35-nutrients-13-00154" ref-type="bibr">35</xref>]. The potential cytotoxicity of co-administrated formulas on HeLa cells were dose-dependently and remarkably greater than those of free MMC. Endurance of Fr-MMC to the nuclei apoptosis was at a lower concentration. Furthermore, Fr-MMC was reported to have the least % of florescence uptake compared to Gi-MMC. Chatterjee et al. observed the in vitro anti-cancer activity and in vivo anti-tumor potential of resveratrol and pterostilbene on HeLa cells [<xref rid="B44-nutrients-13-00154" ref-type="bibr">44</xref>]. The result of in vitro showed cytotoxic potential of both compounds, exhibiting the ability to inhibit viral oncogene E6. In vivo analysis showed inhibition of E6 and VEGF tumor protein levels. Moreover, the decline in tumor size in pterostilbene was related to activated caspase-3, while resveratrol-treated mice was related to arrest of cell cycle. The study of Chen et al. observed the anti-tumor efficacy of Tf-CT-MEs, by using transmission electron microscopy, dynamic light scattering, flow cytometry, and MTT assay [<xref rid="B45-nutrients-13-00154" ref-type="bibr">45</xref>]. Moreover, intratumor penetration was discovered by 3D tumor spheroid as the model. The result showed that Tf-CT-ME had higher apoptotic effects than those treated by CT-MEs.</p><p>Most studies on apoptosis of compounds were confirmed by mechanisms such as caspase, Bcl-2, Bax, ROS, PARP, and p-Akt. Among the mechanisms, the three most important were the regulation of caspase, Bcl-2, and Bax. Significant loss or inactivation of caspase impairs the induction of apoptosis, leading to a dramatic imbalance in growth dynamics, ultimately causing abnormal growth of human cancer [<xref rid="B52-nutrients-13-00154" ref-type="bibr">52</xref>]. Of the 30 compounds that induce apoptosis in cervical cancer, caspase-inducing compounds were the most common out of 19, and 16 of them induced caspase-3 expression. Caspase-9 was induced in eight compounds, caspase-7, -8, and c-caspase-3 were expressed in three, and c-caspase-9 in two. Bcl-2, which affects apoptosis and drug resistance [<xref rid="B53-nutrients-13-00154" ref-type="bibr">53</xref>], was regulated in 13 compounds, and Bax, a pro-apoptotic molecule that also functions as a tumor suppressor [<xref rid="B54-nutrients-13-00154" ref-type="bibr">54</xref>], was regulated in 10 compounds. There were nine compounds that inhibit Bcl-2 and two compounds that increase it, eight compounds that increase Bax, and two compounds have apoptosis by controlling the ratio of Bax and Bcl-2. Most of the studies were performed in vitro, but there were some studies performed in vivo [<xref rid="B28-nutrients-13-00154" ref-type="bibr">28</xref>,<xref rid="B38-nutrients-13-00154" ref-type="bibr">38</xref>,<xref rid="B44-nutrients-13-00154" ref-type="bibr">44</xref>]. A large number of studies have revealed the mechanism of apoptosis, but few studies have found it [<xref rid="B23-nutrients-13-00154" ref-type="bibr">23</xref>,<xref rid="B27-nutrients-13-00154" ref-type="bibr">27</xref>,<xref rid="B35-nutrients-13-00154" ref-type="bibr">35</xref>,<xref rid="B50-nutrients-13-00154" ref-type="bibr">50</xref>]. In addition, there have been studies where the concentration is too high, and toxicity is a concern [<xref rid="B24-nutrients-13-00154" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-13-00154" ref-type="bibr">25</xref>,<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-13-00154" ref-type="bibr">30</xref>,<xref rid="B39-nutrients-13-00154" ref-type="bibr">39</xref>,<xref rid="B45-nutrients-13-00154" ref-type="bibr">45</xref>].</p></sec><sec id="sec3dot1dot2-nutrients-13-00154"><title>3.1.2. Extracts</title><p>The 19 natural extracts have been found to induce cell death in cervical cancer (<xref rid="nutrients-13-00154-t002" ref-type="table">Table 2</xref>). Swanepoel et al. showed that aqueous extracts of <italic>Anemone nemorosa</italic> caused a delay in the early mitosis phase of the cell cycle [<xref rid="B55-nutrients-13-00154" ref-type="bibr">55</xref>]. Apoptosis was confirmed through fluorescent staining with annexin V-FITC. The treatment with IC<sub>50</sub> concentration of 20.33 &#x000b1; 2.480 &#x000b5;g/mL elevated the expression level of PS translocation, c-caspase-3, -8, and ROS in 24 h. In 48 h, however, the level of MMP and ROS were suppressed. The result of this study indicated that induction of apoptosis and autophagy and inhibition of proliferation were induced in the pathway. Aril extracts isolated from <italic>Strelitzia nicolai</italic> induced apoptosis and inhibited oxidant in HeLa cells at a concentration of 250 &#x003bc;g/mL for an incubation time of 24 h, 48 h, and 72 h [<xref rid="B56-nutrients-13-00154" ref-type="bibr">56</xref>]. The aril extracts decreased cell viability by 52% and induced apoptosis in HeLa cells. Additionally, aril extracts produced a higher radical scavenging activity than the bilirubin standard. Ethanol extracts from <italic>Astragalus membranaceus</italic>, <italic>Angelica gigas</italic>, and <italic>Trichosanthes kirilowii</italic> upregulated c-caspase-3, -8, and PARP-1 and downregulated Bax, cyclin D, CDK2, CDK4, CDK6, and p27 in HeLa cells at doses of 100 &#x003bc;g/mL, 200 &#x003bc;g/mL, and 400 &#x003bc;g/mL for 24 h and 48 h [<xref rid="B57-nutrients-13-00154" ref-type="bibr">57</xref>]. This result suggested that induction of apoptosis, cell cycle arrest, and reduction of cell viability are involved in the pathway. However, ethanol extracts did not affect the intrinsic mitochondria-mediated apoptosis pathway in HeLa cells. Expression of c-caspase-3, -8, RIP, and TNF-R1 were increased and MMP-2 and-9 were decreased in HeLa cells by treatment of ethanol extracts from <italic>Bauhinia variegate candida</italic> at dose of 15 &#x003bc;g/mL for an incubation time of 24 h [<xref rid="B58-nutrients-13-00154" ref-type="bibr">58</xref>]. Controlling mechanisms, it could reduce cell viability and inhibit migration and induct apoptosis. In conclusion, it contained components with potential tumor-selective cytotoxic action. Ethanol extracts isolated from <italic>Botryidiopsidaceae</italic> species induced apoptosis and inhibited oxidant, proliferation, migration, and invasion in HeLa cells [<xref rid="B59-nutrients-13-00154" ref-type="bibr">59</xref>]. It upregulated p53 and c-caspase-3 and downregulated Bcl-2 at doses of 6.25 &#x003bc;g/mL, 12.5 &#x003bc;g/mL, 25 &#x003bc;g/mL, and 50 &#x003bc;g/mL for an incubation time of 24 h. In conclusion, inhibitory effects of ethanol extracts on migration and invasion might occur via the modulation of genes related to the processes of cellular invasion and migration. Ethanol extracts from <italic>Chloromonas</italic> species upregulated c-caspase-3 and p53 and downregulated Bcl-2 in HeLa cells at dose of 12.5 &#x003bc;g/mL and 25 &#x003bc;g/mL for an incubation time of 24 h and 72 h [<xref rid="B60-nutrients-13-00154" ref-type="bibr">60</xref>]. The result meant that ethanol extracts dealt with cancer cells by increasing the pro-apoptotic protein and reducing the anti-apoptotic protein. It suggested that induction of apoptosis through the modulation of apoptosis associated genes and inhibition of proliferation and oxidant were involved in the pathway. Ethanol extracts from <italic>Dendrobium chrysanthum</italic> upregulated Bax, and p53 and downregulated Bcl-2 in HeLa cells at the density of 450 &#x003bc;g/mL for an incubation time of 24 h [<xref rid="B61-nutrients-13-00154" ref-type="bibr">61</xref>]. This suggested that induction of apoptosis, DNA fragmentation, and ROS-altered cell morphology were involved in the pathway. In addition, the anticancer potential of the <italic>Dendrobium chrysanthum</italic> was mediated through p53-dependent apoptosis. In vivo, antitumor activity exhibited a significant increase in the life span of Dalton&#x02019;s lymphoma-bearing mice with significant decrease in abdominal size along with reduced tumor ascites. Ethanol extracts from <italic>Rhamnus sphaerosperma</italic> var. <italic>pubescens</italic> (EERs) reduced activation of HOCl/OCl- and p-Akt at 25 &#x003bc;g/mL, 50 &#x003bc;g/mL, and 100 &#x003bc;g/mL for 6 h, 12 h, and 24 h for the treatment of SiHa and C33A cells [<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]. The result showed that EERs were related to the induction of cell cytotoxicity, apoptosis, oxidative stress, and DNA damage. Ma et al. reported that EAEG, ethyl acetate extracts of <italic>Gynura formosana</italic> Kitam. leaves, exhibited antioxidant, anti-inflammatory, and autophagy-mediated inhibition of cell proliferation activity on HeLa cells [<xref rid="B62-nutrients-13-00154" ref-type="bibr">62</xref>]. The increased levels of LC3-II/LC3-I and decreased levels of P62/GAPDH and MCM7/GAPDH were observed at a concentration of 30 &#x000b5;g/mL for 72 h. Kuriakose et al. reported that ethyl acetate extracts of <italic>Penicillium sclerotiorum</italic>, isolated from <italic>Cassia fistula</italic> L., had cytotoxic activity [<xref rid="B63-nutrients-13-00154" ref-type="bibr">63</xref>]. At doses of 5 &#x003bc;g/mL, 25 &#x003bc;g/mL, and 50 &#x003bc;g/mL for 24 h, it arrested cells at S and G2/M phase of the cell cycle in a dose-dependent manner. Annexin V/propidium iodide double staining showed apoptosis more than necrosis. Moreover, the decreased Bcl-2 and increased Bax, p53, and Apaf-1 support apoptotic cell death. Ethyl acetate extracts from <italic>Streptomyces</italic> species upregulated caspase-3, -9, Bax, and LC3-II and downregulated PARP, LC3-I, Beclin1, and p62 in SiHa cells at concentrations of 20 &#x003bc;g/mL, 40 &#x003bc;g/mL, and 60 &#x003bc;g/mL for 24 h [<xref rid="B64-nutrients-13-00154" ref-type="bibr">64</xref>]. Half of the SiHa cells underwent death at a concentration of 20 &#x003bc;g/mL. This induced altered cell morphology and apoptosis, autophagy, and inhibited proliferation in the pathway. Consequently, ethyl acetate extracts-induced Bax-dependent mitochondrial permeabilization plays the role of an initiator of intrinsic pathway of apoptosis. Expression of p53 was increased and cyclin D, E, p21, and survivin were decreased in SiHa cells by treatment of blueberry extracts at the density of 50 mg/mL for an incubation time of 24 h with 4 Gy radiotherapy [<xref rid="B65-nutrients-13-00154" ref-type="bibr">65</xref>]. Through the mechanisms, it enhanced radiotherapy. Lipid-soluble extracts from <italic>Pinellia pedatisecta</italic> Schott. upregulated &#x003b2;-catenin, c-Myc, cyclin D1, PPAR1, and downregulated Th2 and Th17 in HPV and TC-1 cells at a dose of 500 &#x003bc;g/mL dealing with 72 h [<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]. This result suggested that induction of apoptosis and cell cycle arrest were involved in the pathway. The subset proportion of Th1 cells increased significantly and both Th2 cells and Th17 cells decreased profoundly. In vivo, T lymphocyte infiltration in tumor-burdened mice was enhanced with treatment. Methanol extracts from <italic>Allium atroviolaceum</italic> upregulated caspase-3, -5, and -9 and downregulated Bcl-2, CDK1, and p53 in HeLa cells at concentrations of 20 &#x003bc;g/mL, 40 &#x003bc;g/mL, 60 &#x003bc;g/mL, 80 &#x003bc;g/mL, and 100 &#x003bc;g/mL for 24 h, 48 h, and 72 h [<xref rid="B67-nutrients-13-00154" ref-type="bibr">67</xref>]. The efficacy was the best at 72 h. Controlling the mechanisms, it inhibited cell growth and proliferation, induced cell cycle arrest, and reduced cell viability. The level of caspase-3 was increased and the level of PARP-1 was decreased by methanol extracts from <italic>Corylus avellane</italic> in HeLa cells at dose of 250 &#x003bc;g/mL and 500 &#x003bc;g/mL for 24 h [<xref rid="B68-nutrients-13-00154" ref-type="bibr">68</xref>]. The expression of cleaved forms of caspase-3 and PARP-1 suggested that the extracts induced apoptosis through caspase-3 activation in HeLa cells. In conclusion, this result suggested that reduction of cell viability, induction of apoptosis, inhibition of oxidant and proliferation were involved in the pathway. Methanol extracts isolated from <italic>Cyperus rotundus</italic> induced apoptosis and DNA fragmentation and inhibited migration in HeLa cells at doses of 25 &#x003bc;g/mL, 50 &#x003bc;g/mL, and 100 &#x003bc;g/mL for an incubation time of 24 h and 48 h [<xref rid="B69-nutrients-13-00154" ref-type="bibr">69</xref>]. Cytotoxic effects of methanol extracts on the tested cancer cell lines ranged from 4.52 &#x000b1; 0.57 &#x003bc;g/mL<sup>&#x02212;1</sup> to 9.85 &#x000b1; 0.68 &#x003bc;g/mL<sup>&#x02212;1</sup>. Moreover, methanol extracts showed anticancer and antimigration activity and it also induced nuclear fragmentation in HeLa cells. Expression of Bax, BAD, caspase-3, p21, and p53 were increased and Bcl-2 was decreased in HeLa cells by treatment of methanol extracts isolated from <italic>Polyalthia longifolia</italic> at dose of 22 &#x003bc;g/mL for 6 h, 12 h, 24 h, 36 h [<xref rid="B70-nutrients-13-00154" ref-type="bibr">70</xref>]. Controlling the mechanisms, it altered cell morphology and induced apoptosis. Consequently, extracts produced distinctive porphological features of HeLa cell death that corresponds to apoptosis. Sul&#x02019;ain et al. reported that the methanol extracts of <italic>Pyrrosia piloselloides</italic> showed antiproliferative effects on HeLa cells [<xref rid="B71-nutrients-13-00154" ref-type="bibr">71</xref>]. This efficacy was caused by treatment with an IC<sub>50</sub> of 16.25 &#x003bc;g/mL. Meanwhile, <italic>Pyrrosia piloselloides</italic> water extracts were without influence. Panicker et al. reported that methanol extracts from <italic>Teucrium mascatense</italic> were shown to activate caspases and PARP on HeLa cells, following treatment with 25 &#x000b5;g/mL, 50 &#x000b5;g/mL, 125 &#x000b5;g/mL, and 250 &#x000b5;g/mL, for 72 h [<xref rid="B72-nutrients-13-00154" ref-type="bibr">72</xref>]. In addition, cell rounding, shrinkage, and detachment from other cells were shown by methanol extracts. This result suggested apoptosis and alteration of cell morphology were related to the pathway.</p><p>Most studies on apoptosis of extracts were confirmed by mechanisms such as caspase, Bcl-2, Bax, and PARP. Of the 19 extracts that induce apoptosis in cervical cancer, the expression of caspase was most common in 10, but c-caspase expression was higher than that of the compounds. The expression of c-caspase-3 was found in five extracts, c-caspase-8 and caspase-3 in four, caspase-9 in two, and c-caspase-7, -9, and caspase-5 was derived from one each. There were six extracts that inhibit Bcl-2, four extracts that increase Bax, and one extracts that decreases it. There were four extracts that regulated the expression of PARP, which played a firm role in DNA repair processes and developed as chemotherapy sensitizers for cancer treatment [<xref rid="B73-nutrients-13-00154" ref-type="bibr">73</xref>]. There were two studies performed both in vivo [<xref rid="B61-nutrients-13-00154" ref-type="bibr">61</xref>,<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]. Most of the studies have revealed the mechanism of apoptosis, but few studies have found it [<xref rid="B56-nutrients-13-00154" ref-type="bibr">56</xref>,<xref rid="B69-nutrients-13-00154" ref-type="bibr">69</xref>,<xref rid="B71-nutrients-13-00154" ref-type="bibr">71</xref>]. There were also studies concerned about toxicity due to experiments conducted at high concentrations [<xref rid="B56-nutrients-13-00154" ref-type="bibr">56</xref>,<xref rid="B57-nutrients-13-00154" ref-type="bibr">57</xref>,<xref rid="B61-nutrients-13-00154" ref-type="bibr">61</xref>,<xref rid="B65-nutrients-13-00154" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>,<xref rid="B68-nutrients-13-00154" ref-type="bibr">68</xref>,<xref rid="B72-nutrients-13-00154" ref-type="bibr">72</xref>].</p></sec></sec><sec id="sec3dot2-nutrients-13-00154"><title>3.2. Anti-angiogenesis</title><p>Angiogenesis is a major cause in the development and metastasis of a variety of tumor types [<xref rid="B74-nutrients-13-00154" ref-type="bibr">74</xref>]. Local angiogenesis provides oxygen and essential nutrients to the growing tumor, supports tumor expansion and invasion into nearby normal tissue, and is essential for distant metastasis [<xref rid="B75-nutrients-13-00154" ref-type="bibr">75</xref>]. To be specific, in cervical cancer, angiogenesis plays a leading role in initiation, proliferation, and progression, and also relates to blocking p53 and stabilizing hypoxia-inducible factor-1&#x003b1;, which led to expression of VEGF [<xref rid="B76-nutrients-13-00154" ref-type="bibr">76</xref>]. So, preventing angiogenesis could be significant in treatment of the disease. Four natural products have this ability toward HeLa cells and CaSki cells (<xref rid="nutrients-13-00154-t003" ref-type="table">Table 3</xref>). When HeLa cells were treated by <italic>Praecitrullus fistulosus</italic> lectin protein (PfLP), which was grown and consumed in subtropical countries, MMP-2 and -9 became downregulated and it led to the induction of apoptosis and inhibition of angiogenesis [<xref rid="B77-nutrients-13-00154" ref-type="bibr">77</xref>]. This mechanism was efficient at a dose of 50 &#x000b5;g/mL with 24 h. In vivo, anticancer and anti-angiogenic properties of PfLP were observed at dose of 10 mg/kg on day 7, 9, and 11 after the tumor cell transplantation. Moreover, it did not show any side effects or secondary complications in the study. Purified Flaxseed hydrolysate (PFH), extracted from lignan, was shown to induce apoptosis and inhibit angiogenesis and metastasis on HeLa cells [<xref rid="B15-nutrients-13-00154" ref-type="bibr">15</xref>]. This process was caused by increasing caspase-3 and downregulating MMP-2 and VEGF. The efficient dose was 17.4 &#x000b5;g/mL, dealing with a timeframe of 48 h. These results suggest that PFH could be great treatment with its anticancer activity. Based on our findings, Kuriakose et al. reported that expression of Bax, p53, and Apaf-1 were increased and Bcl-2 was decreased in HeLa cells by treatment of ethyl acetate extracts of <italic>Penicillium sclerotiorum</italic> from <italic>Cassia fistula</italic> L. [<xref rid="B63-nutrients-13-00154" ref-type="bibr">63</xref>]. Hexadecanoic acid, oleic acid, and benzoic acid were the major active parts in this treatment. Through controlling mechanisms, it could induce cell cycle arrest and inhibit angiogenesis at a dose of 7.75 &#x000b5;g/mL. Seifaddinipour et al. reported that ethyl acetate extracts isolated from <italic>Pistacia vera</italic> L. downregulated TNF, Bcl-2, IAP, and TRAF in CaSki cells [<xref rid="B78-nutrients-13-00154" ref-type="bibr">78</xref>]. Through the mechanisms, it induced apoptosis and inhibited angiogenesis. The efficient dose was 81.17 &#x000b1; 2.87 &#x000b5;g/mL, dealing with a timeframe of 72 h.</p><p>A total of four natural products exhibited anti-angiogenesis, and the mechanisms were very diverse. MMP performs a complex and important role in cancer growth and metastasis [<xref rid="B79-nutrients-13-00154" ref-type="bibr">79</xref>], and two substances inhibit it. Bcl-2 was inhibited by two substances, and in addition, it showed an anti-angiogenesis effect through a mechanism that inhibits factors such as VEGF, TNF, and IAP. In the study using <italic>Penicillium sclerotiorum</italic>, the concentration of the substance (7.75 &#x000b5;g/mL) was significantly lower than that of other anti-angiogenesis studies [<xref rid="B63-nutrients-13-00154" ref-type="bibr">63</xref>]. By increasing the expression of Bax, p53, and Apaf-1 and inhibiting Bcl-2, it was shown to induce not only anti-angiogenesis, but also cell cycle arrest and apoptosis at doses of 5 &#x000b5;g/mL, 25 &#x000b5;g/mL, and 50 &#x000b5;g/mL.</p></sec><sec id="sec3dot3-nutrients-13-00154"><title>3.3. Anti-Metastasis</title><p>Metastasis is the propagation of transformed cells from the organ of origin to other parts of the body and the successive proliferation of tumor colonies [<xref rid="B80-nutrients-13-00154" ref-type="bibr">80</xref>]. The mechanism includes complicated processes, such as cancer cell detachment from extracellular matrix, migration, invasion, and extravasation to the circulation, and most cancer patients die from metastasis rather than primary tumors [<xref rid="B81-nutrients-13-00154" ref-type="bibr">81</xref>]. Six natural products including EGCG inhibited metastasis (<xref rid="nutrients-13-00154-t004" ref-type="table">Table 4</xref>). The chemical structures of compounds are shown in <xref ref-type="fig" rid="nutrients-13-00154-f002">Figure 2</xref>.</p><p>Expression of E-cadherin was increased and p38 and PI3K were decreased in SiHa cells by treatment of astragaloside IV from Radix Astragali [<xref rid="B82-nutrients-13-00154" ref-type="bibr">82</xref>]. Additionally, astragaloside IV demonstrated inhibition of cell metastasis on SiHa cell lines. The efficient dose was 200 &#x000b5;g/mL, dealing with a timeframe of 24 h. Expression of MMP-2, -9, and VEGF was decreased in HeLa cells by treatment of epigallocatechingallate (EGCG) from green tea [<xref rid="B83-nutrients-13-00154" ref-type="bibr">83</xref>]. Thus, it induced apoptosis at a dose of 50 &#x000b5;g/mL for 48 h. In addition, it inhibited cell metastasis and proliferation in cervical cancer cells by reducing VEGF, CDK2, and ERK1/2. Praeruptorin-B isolated from <italic>Peucedanum praeruptorum</italic> Dunn. downregulated NF-&#x003ba;B, MMP-2, and -9 in HeLa and SiHa cells [<xref rid="B84-nutrients-13-00154" ref-type="bibr">84</xref>]. Inhibition of cell metastasis could be observed following the treatment of praeruptorin-B at doses of 40 &#x000b5;g and 60 &#x000b5;g over 24 h. Moreover, it blocked Akt phosphorylation without affecting the MAPK pathway. These results suggested that praeruptorin-B could be good at anticancer activity, especially in cervical cancer cells. Thymoquinone from <italic>Nigella sativa</italic> was shown to induce apoptosis, migration, and invasion on CaSki and HeLa cells [<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]. It was efficient when CaSki cells and HeLa cells were treated at a concentration of 5 &#x000b5;M for 24 h. Furthermore, it included the mechanism of increasing E-cadherin level and decreasing the level of Twist1 and Zeb1. Ethanol extracts from <italic>Bauhinia variegata candida</italic> decreased the level of MMP-2 and -9 on HeLa cells [<xref rid="B58-nutrients-13-00154" ref-type="bibr">58</xref>]. This mechanism was caused when HeLa cells were treated at a concentration of 25 &#x000b5;g/mL for 24 h. Subsequently, it reduced cell viability, migration, and invasion. Lee et al. reported that the decline of MMP-9 and ERK1/2 was observed after the exposure of <italic>Terminalia catappa</italic> ethanol extracts on HeLa and SiHa cells [<xref rid="B85-nutrients-13-00154" ref-type="bibr">85</xref>]. This process was efficient when the dose was 25 &#x000b5;g/mL, 50 &#x000b5;g/mL, and 75 &#x000b5;g/mL, dealing with a timeframe of 24 h and it led to inhibition of cell metastasis. In conclusion, ethanol extracts blocked the MMP-9 through ERK1/2 pathway by anti-metastatic effects.</p><p>A total of six substances derived from natural products inhibited the metastasis of cervical cancer, and MMP control was the most important mechanism. Four substances regulated MMP, MMP-2 was inhibited in three substances, and MMP-9 was inhibited in four substances. E-cadherin is a protein remarkably related to tumor invasion, metastatic transmission, and poor patient prognosis [<xref rid="B86-nutrients-13-00154" ref-type="bibr">86</xref>]. It was derived from two substances, and in addition, it showed anti-metastasis action through inhibitory mechanisms such as p38, VEGF, and Twist1. In particular, ethanol extracts from <italic>Bauhinia variegate candida</italic> exhibited multi-effect, inhibited migration and invasion at 25 &#x000b5;g/mL, and also induced apoptosis at 15 &#x000b5;g/mL [<xref rid="B58-nutrients-13-00154" ref-type="bibr">58</xref>]. However, the concentration of the natural product was so high (200 &#x000b5;g/mL) that there was a study involving cytotoxicity concerns [<xref rid="B82-nutrients-13-00154" ref-type="bibr">82</xref>].</p></sec><sec id="sec3dot4-nutrients-13-00154"><title>3.4. Drug Resistance</title><p>Drug resistance is multifaceted, which is due to tumor heterogeneity, tumor microenvironment, and so forth [<xref rid="B87-nutrients-13-00154" ref-type="bibr">87</xref>]. It can exist against any effective anticancer drug and can develop in several mechanisms, and unfortunately, in a respectable number of patients, tumors do not respond to the treatment [<xref rid="B88-nutrients-13-00154" ref-type="bibr">88</xref>]. 5 studies reported the natural products that can regulated the drug resistance (<xref rid="nutrients-13-00154-t005" ref-type="table">Table 5</xref> and <xref ref-type="fig" rid="nutrients-13-00154-f003">Figure 3</xref>), and chemical structures of compounds sensitizing drug resistance are shown in <xref ref-type="fig" rid="nutrients-13-00154-f004">Figure 4</xref>.</p><p>When HeLa cells were treated by rosin abietane diterpenoid, which was isolated from pine rosin, the level of caspase-3 and Bax were increased but Bcl-2 was decreased [<xref rid="B89-nutrients-13-00154" ref-type="bibr">89</xref>]. Specifically, the level of Th1 cells were increased and both TH2 cells and TH17 cells were decreased. These processes were efficient when HeLa cells were treated at concentration of 1.08 &#x000b1; 0.12 &#x000b5;M. Finally, it induced apoptosis and cell cycle arrest in HeLa cells. Levrier et al. suggested that thalicthuberine from <italic>Hernandia albiflora</italic> downregulated tubulin polymers on HeLa cells [<xref rid="B90-nutrients-13-00154" ref-type="bibr">90</xref>]. They used HeLa cells expressing the end-binding protein (EB1-GFP) with thalicthuberine. Through this mechanism, it induced apoptosis and cell cycle arrest at a dose of 2.5 &#x000b5;M for 72 h. Thymoquinone from <italic>Nigella sativa</italic> was shown to have apoptotic effect and inhibition of proliferation on SiHa and CaSki cells [<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]. This efficacy was made by upregulating E-cadherin level and downregulating the level of Twist1 and Zeb1; a dose of 5 &#x000b5;M and 10 &#x000b5;M for 24 and 36 h showed the best efficacy. Levels of caspase-3 and -8 were increased on HeLa cells by treatment of 6&#x003b1;-acetoxyanopterine (6-AA) from <italic>Anopterus macleayanus</italic> [<xref rid="B91-nutrients-13-00154" ref-type="bibr">91</xref>]. It induced cell apoptosis and inhibition of proliferation through mitosis, severe mitotic spindle defects, asymmetric cell divisions, and finally mitotic catastrophe. These processes mostly occurred at concentrations of 3.2 nM and 11.6 nM for 48 h. Huang et al. reported that lipid-soluble extracts from <italic>Pinellia pedatisecta</italic> Schott. up-regulated P53 and downregulated ERK, Bcl-2, PCNA, and HPV E6 [<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]. It yielded induction of apoptosis on CaSki and HeLa cells, at a dose of 5000 &#x000b5;g/mL for three days.</p><p>We reviewed a total of five studies and the most common factors affecting multi-drug resistance (MDR) were expression of caspase and inhibition of Bcl-2. Caspase expression was increased in two natural substances, both substances increased the expression of caspase-3, and caspase-8 was induced from one substance. The regulation of MDR through Bcl-2 inhibition appeared in two substances, and expressions of p53, Bax, and E-cadherin were also found in one substance each. Especially, thymoquinone obtained from <italic>Nigella sativa</italic> affects apoptosis, anti-metastasis, and MDR [<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]. At a low concentration of 5 &#x000b5;M, it showed apoptosis induction and inhibitory effects of migration and invasion by increasing E-cadherin and decreasing Twist1 and Zeb1, at 5 &#x000b5;M and 10 &#x000b5;M, apoptosis, proliferation, and MDR were controlled through the same mechanism. At concentrations of 10 &#x000b5;M, 20 &#x000b5;M, and 40 &#x000b5;M, the effects of apoptosis, anti-migration, anti-invasion, and anti-growth were found, by increasing Bax and E-cadherin. Additionally, the lipid-soluble extracts of <italic>Pinellia pedatisecta</italic> Schott. induced cell cycle arrest and apoptosis at 500 &#x000b5;g/mL, and affects apoptosis and MDR at 5000 &#x000b5;g/mL [<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]. However, it should be considered that the experiment is done by an extremely high dose.</p></sec><sec id="sec3dot5-nutrients-13-00154"><title>3.5. MicroRNA Regulation</title><p>MicroRNAs, short non-coding RNAs that could regulate gene expression, could regulate various cellular processes [<xref rid="B92-nutrients-13-00154" ref-type="bibr">92</xref>]. They perform in a feedback structure by protecting key biological processes including cell proliferation, differentiation, and apoptosis, and regulate tumor formation and the development and progression of malignant tumors [<xref rid="B93-nutrients-13-00154" ref-type="bibr">93</xref>]. It is possible since miRNAs can target many genes, and also one gene can be targeted by different miRNAs [<xref rid="B94-nutrients-13-00154" ref-type="bibr">94</xref>]. There are important scientific studies showing the usefulness of miRNAs as biomarkers for prediction, diagnosis, and prognosis, and there is also evidence that suppression of oncogenic miRNAs or replacement of tumor suppressor miRNAs could be used to develop new therapeutic strategies [<xref rid="B95-nutrients-13-00154" ref-type="bibr">95</xref>].</p><p>Two studies were reported to suppress the cervical cancer via miRNA regulation (<xref rid="nutrients-13-00154-t006" ref-type="table">Table 6</xref> and <xref ref-type="fig" rid="nutrients-13-00154-f005">Figure 5</xref>). 1&#x02032;S-1&#x02032;-acetoxychavicol acetate (ACA) from <italic>Alpinia conchigera</italic> upregulated SMAD4 and downregulated miR-210, which led induction of apoptosis and inhibition of proliferation on SiHa and CaSki cells [<xref rid="B20-nutrients-13-00154" ref-type="bibr">20</xref>]. It was evident at doses of 20 &#x000b5;M and 30 &#x000b5;M for 6 h and 12 h. The result of study suggested that combination of miRNAs could be a new strategy in treating cervical cancer. Phuah et al. elucidated that ACA from <italic>Alpinia conchigera</italic> induced apoptosis and inhibited proliferation by increasing caspase-3 and -8 and decreasing miR-629 in SiHa and CaSki cells [<xref rid="B48-nutrients-13-00154" ref-type="bibr">48</xref>]. It was evident at concentrations of 20 &#x000b5;M and 30 &#x000b5;M for 6 h, 12 h, and 48 h. This result suggested the potential of ACA with miR-629 as a cervical cancer treatment. Furthermore, apoptosis was also observed via increasing the expression of RSU1 and GAPDH at the same concentrations.</p></sec></sec><sec id="sec4-nutrients-13-00154"><title>4. Previous Studies</title><p>Cervical cancer is the fourth leading cause of cancer death in women, the most commonly diagnosed cancer in 28 countries, and the leading cause of cancer death in 42 countries [<xref rid="B2-nutrients-13-00154" ref-type="bibr">2</xref>]. Surgery, radiotherapy, and chemotherapy are being performed for cervix cancer, but side effects and complications can occur, so a new potent treatment for cervical cancer by natural products is attracting attention. In 2002, de MOURA et al. reported a review article about natural products that inhibit cervical cancer, however it was a decade ago [<xref rid="B96-nutrients-13-00154" ref-type="bibr">96</xref>]. A systematic review paper was published in 2013 that analyzed 20 clinical trials; retinoids, vitamin E, probiotics, indoles, multivitamin, folic acid, and selenium were summarized, but the number of substances was not large, and since the paper was published in 2013, the latest research is not included [<xref rid="B97-nutrients-13-00154" ref-type="bibr">97</xref>]. Wang et al. reviewed plants that have various effects on cervical cancer, divided by their mechanism including apoptosis, cell cycle arrest, anti-migration, and anti-invasion [<xref rid="B98-nutrients-13-00154" ref-type="bibr">98</xref>]. However, this study was also published in 2013 and does not include anti-angiogenesis, multi-drug resistance, and miRNAs. Lastly, there was a study that introduced natural treatments, which summarized in vitro and in vivo studies on the effects of various substances on cervical cancer and substances that enhance the efficacy of anticancer and radiation therapy [<xref rid="B99-nutrients-13-00154" ref-type="bibr">99</xref>]. However, this study was published in 2015 and is not organized according to each mechanism. Therefore, it is necessary to investigate the latest research on natural products effective in cervical cancer, with systematic review and mechanism arrangement of the processes such as apoptosis.</p></sec><sec id="sec5-nutrients-13-00154"><title>5. Limitation and Strength</title><p>The limitation of our review was that studies on decoctions and that are older than three years are not included, and clinical trials were not searched. Although natural products were effective in inhibiting cervical cancer cells, there are still variations in stabilization and toxicity. In the above, the latest studies of natural products with various effects on cervical cancer were examined, and various mechanisms, concentrations, and experimental models were reviewed. The ultimate goal of our study is to find new therapeutic substances that are effective against cervical cancer and have fewer side effects. Because natural products have fewer side effects, they may have potential as an alternative therapy for cervical cancer. In order to use natural products in clinical practice, additional research is needed to find the most effective and minimally toxic doses for humans. Studies on the synergistic effects of natural products and cervical cancer surgery, radiation, and chemotherapy are also needed. We look forward to further research on finding substances with excellent anticancer effects and hope that this research will be the basis for finding new treatment substances for cervical cancer.</p></sec><sec sec-type="conclusions" id="sec6-nutrients-13-00154"><title>6. Conclusions</title><p>Our study reviewed the natural products that have anti-tumor effects on cervical cancer. Through various mechanisms, 64 natural products exhibited apoptosis, anti-angiogenesis, anti-metastasis effects and regulated multi-drug resistance and miRNAs. Most of the natural products (47) induced apoptosis including curcumin, emodin, and <italic>Penicillium sclerotiorum</italic>. Four natural products, including Lignan and <italic>Pistacia vera</italic> L., showed anti-angiogenic property in cervical cancer cells. EGCG and five other natural products inhibited metastasis of cervical cancer. Five studies reported that pine rosin and other natural products sensitized drug resistance in cervical cancer. There are few studies that demonstrated miRNA regulating effect of natural products. We expect the non-clinical findings of this study to serve as the groundwork for finding novel cervical cancer treatments that can be used in clinic with less side effects.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Investigation, M.K., S.L., and W.J.; data curation, S.-H.P., M.K., S.L., W.J., and B.K.; writing&#x02014;original draft preparation, S.-H.P., M.K., S.L., and W.J.; writing&#x02014;review and editing, S.-H.P., M.K., and B.K.; visualization, S.-H.P.; supervision, S.-H.P. and B.K.; project administration, S.-H.P. and B.K.; funding acquisition, B.K. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1I1A2066868), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1A5A201941311), a grant of the Korea Health Technology R&#x00026;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &#x00026; Welfare, Republic of Korea (grant number: HF20C0116), and a grant of the Korea Health Technology R&#x00026;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &#x00026; Welfare, Republic of Korea (grant number: HB20C0038).</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are openly available in [Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review. <italic>Nutrients</italic>
<bold>2021</bold>, <italic>13</italic>, 154.] at [<uri xlink:href="https://doi.org/10.3390/nu13010154">https://doi.org/10.3390/nu13010154</uri>], reference number [99]. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-13-00154"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urasa</surname><given-names>M.</given-names></name><name><surname>Darj</surname><given-names>E.</given-names></name></person-group><article-title>Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania</article-title><source>Afr. Health Sci.</source><year>2011</year><volume>11</volume><fpage>48</fpage><lpage>57</lpage><?supplied-pmid 21572857?><pub-id pub-id-type="pmid">21572857</pub-id></element-citation></ref><ref id="B2-nutrients-13-00154"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Torre</surname><given-names>L.A.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J. Clin.</source><year>2018</year><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><?supplied-pmid 30207593?><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="B3-nutrients-13-00154"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Byun</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Nam</surname><given-names>J.-H.</given-names></name></person-group><article-title>Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer</article-title><source>Gynecol. Oncol.</source><year>2017</year><volume>144</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2016.10.032</pub-id><?supplied-pmid 27789082?><pub-id pub-id-type="pmid">27789082</pub-id></element-citation></ref><ref id="B4-nutrients-13-00154"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertlein</surname><given-names>M.L.</given-names></name><name><surname>Lenhard</surname><given-names>M.</given-names></name><name><surname>Kirschenhofer</surname><given-names>A.</given-names></name><name><surname>Kahlert</surname><given-names>S.</given-names></name><name><surname>Mayr</surname><given-names>D.</given-names></name><name><surname>Burges</surname><given-names>A.</given-names></name><name><surname>Friese</surname><given-names>K.</given-names></name></person-group><article-title>Cetuximab monotherapy in advanced cervical cancer: A retrospective study with five patients</article-title><source>Arch. Gynecol. Obstet.</source><year>2011</year><volume>283</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1007/s00404-010-1389-1</pub-id><?supplied-pmid 20180130?><pub-id pub-id-type="pmid">20180130</pub-id></element-citation></ref><ref id="B5-nutrients-13-00154"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtz</surname><given-names>J.</given-names></name><name><surname>Hardy-Bessard</surname><given-names>A.-C.</given-names></name><name><surname>Deslandres</surname><given-names>M.</given-names></name><name><surname>Lavau-Denes</surname><given-names>S.</given-names></name><name><surname>Largillier</surname><given-names>R.</given-names></name><name><surname>Roemer-Becuwe</surname><given-names>C.</given-names></name><name><surname>Weber</surname><given-names>B.</given-names></name><name><surname>Guillemet</surname><given-names>C.</given-names></name><name><surname>Paraiso</surname><given-names>D.</given-names></name><name><surname>Pujade-Lauraine</surname><given-names>E.</given-names></name></person-group><article-title>Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial</article-title><source>Gynecol. Oncol.</source><year>2009</year><volume>113</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2008.12.040</pub-id><pub-id pub-id-type="pmid">19232434</pub-id></element-citation></ref><ref id="B6-nutrients-13-00154"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaffney</surname><given-names>D.K.</given-names></name><name><surname>Winter</surname><given-names>K.</given-names></name><name><surname>Dicker</surname><given-names>A.P.</given-names></name><name><surname>Miller</surname><given-names>B.</given-names></name><name><surname>Eifel</surname><given-names>P.J.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name><name><surname>Avizonis</surname><given-names>V.</given-names></name><name><surname>Fromm</surname><given-names>M.</given-names></name><name><surname>Greven</surname><given-names>K.</given-names></name></person-group><article-title>A Phase II study of acute toxicity for Celebrex&#x02122; (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG</article-title><source>Int. J. Radiat. Oncol.</source><year>2007</year><volume>67</volume><fpage>104</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2006.08.002</pub-id><?supplied-pmid 17084549?><pub-id pub-id-type="pmid">17084549</pub-id></element-citation></ref><ref id="B7-nutrients-13-00154"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>F.G.</given-names></name><name><surname>Chan</surname><given-names>P.</given-names></name><name><surname>Doll</surname><given-names>C.</given-names></name><name><surname>Milosevic</surname><given-names>M.</given-names></name><name><surname>Oza</surname><given-names>A.</given-names></name><name><surname>Syed</surname><given-names>A.</given-names></name><name><surname>Pintilie</surname><given-names>M.</given-names></name><name><surname>Levin</surname><given-names>W.</given-names></name><name><surname>Manchul</surname><given-names>L.</given-names></name><name><surname>Fyles</surname><given-names>A.</given-names></name></person-group><article-title>A prospective phase I&#x02013;II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment</article-title><source>Int. J. Radiat. Oncol.</source><year>2007</year><volume>67</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2006.08.024</pub-id><?supplied-pmid 17056201?><pub-id pub-id-type="pmid">17056201</pub-id></element-citation></ref><ref id="B8-nutrients-13-00154"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Broutet</surname><given-names>N.</given-names></name><name><surname>Eckert</surname><given-names>L.</given-names></name><name><surname>Ullrich</surname><given-names>A.</given-names></name><name><surname>Bloem</surname><given-names>P.</given-names></name></person-group><source>Comprehensive Cervical Cancer Control: A Guide to Essential Practice</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2014</year><fpage>1</fpage><lpage>378</lpage></element-citation></ref><ref id="B9-nutrients-13-00154"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Jeong</surname><given-names>M.I.</given-names></name><name><surname>Kim</surname><given-names>H.-R.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Moon</surname><given-names>W.-K.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name></person-group><article-title>Plant Extracts as Possible Agents for Sequela of Cancer Therapies and Cachexia</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>836</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9090836</pub-id></element-citation></ref><ref id="B10-nutrients-13-00154"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Muz</surname><given-names>B.</given-names></name><name><surname>Alhallak</surname><given-names>K.</given-names></name><name><surname>Cosper</surname><given-names>P.F.</given-names></name><name><surname>Muhammad</surname><given-names>N.</given-names></name><name><surname>Jeske</surname><given-names>A.</given-names></name><name><surname>Hinger</surname><given-names>A.</given-names></name><name><surname>Markovina</surname><given-names>S.</given-names></name><name><surname>Grigsby</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side-Effect Profile</article-title><source>Int. J. Radiat. Oncol.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.ijrobp.2020.11.052</pub-id></element-citation></ref><ref id="B11-nutrients-13-00154"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>D.-W.</given-names></name><name><surname>Pouliot</surname><given-names>L.M.</given-names></name><name><surname>Hall</surname><given-names>M.D.</given-names></name><name><surname>Gottesman</surname><given-names>M.M.</given-names></name></person-group><article-title>Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes</article-title><source>Pharmacol. Rev.</source><year>2012</year><volume>64</volume><fpage>706</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1124/pr.111.005637</pub-id><pub-id pub-id-type="pmid">22659329</pub-id></element-citation></ref><ref id="B12-nutrients-13-00154"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>A.J.</given-names></name><name><surname>Jhingran</surname><given-names>A.</given-names></name><name><surname>Frumovitz</surname><given-names>M.</given-names></name><name><surname>Ramondetta</surname><given-names>L.</given-names></name><name><surname>Bodurka</surname><given-names>D.C.</given-names></name></person-group><article-title>Patient Preferences for Side Effects Associated With Cervical Cancer Treatment</article-title><source>Int. J. Gynecol. Cancer</source><year>2014</year><volume>24</volume><fpage>1077</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1097/IGC.0000000000000149</pub-id><?supplied-pmid 24905618?><pub-id pub-id-type="pmid">24905618</pub-id></element-citation></ref><ref id="B13-nutrients-13-00154"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momtazi-Borojeni</surname><given-names>A.A.</given-names></name><name><surname>Ghasemi</surname><given-names>F.</given-names></name><name><surname>Hesari</surname><given-names>A.</given-names></name><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Caraglia</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Anti-Cancer and Radio-Sensitizing Effects of Curcumin in Nasopharyngeal Carcinoma</article-title><source>Curr. Pharm. Des.</source><year>2018</year><volume>24</volume><fpage>2121</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.2174/1381612824666180522105202</pub-id><?supplied-pmid 29788875?><pub-id pub-id-type="pmid">29788875</pub-id></element-citation></ref><ref id="B14-nutrients-13-00154"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasreen</surname><given-names>S.</given-names></name><name><surname>Safeer</surname><given-names>S.</given-names></name><name><surname>Dar</surname><given-names>K.K.</given-names></name><name><surname>Andleeb</surname><given-names>S.</given-names></name><name><surname>Ejaz</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.A.</given-names></name><name><surname>Ali</surname><given-names>S.</given-names></name></person-group><article-title>Etiology of hepatocellular carcinoma and treatment through medicinal plants: A comprehensive review</article-title><source>Orient. Pharm. Exp. Med.</source><year>2018</year><volume>18</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1007/s13596-018-0330-1</pub-id></element-citation></ref><ref id="B15-nutrients-13-00154"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezzat</surname><given-names>S.M.</given-names></name><name><surname>Shouman</surname><given-names>S.A.</given-names></name><name><surname>ElKhoely</surname><given-names>A.</given-names></name><name><surname>Attia</surname><given-names>Y.M.</given-names></name><name><surname>Elsesy</surname><given-names>M.E.</given-names></name><name><surname>El Senousy</surname><given-names>A.S.</given-names></name><name><surname>Choucry</surname><given-names>M.A.</given-names></name><name><surname>El Gayed</surname><given-names>S.H.</given-names></name><name><surname>El Sayed</surname><given-names>A.A.</given-names></name><name><surname>Sattar</surname><given-names>E.A.</given-names></name><etal/></person-group><article-title>Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>544</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-18944-0</pub-id><?supplied-pmid 29323210?><pub-id pub-id-type="pmid">29323210</pub-id></element-citation></ref><ref id="B16-nutrients-13-00154"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name></person-group><article-title>miR-300/FA2H affects gastric cancer cell proliferation and apoptosis</article-title><source>Open Med.</source><year>2020</year><volume>15</volume><fpage>882</fpage><lpage>889</lpage><pub-id pub-id-type="doi">10.1515/med-2020-0188</pub-id></element-citation></ref><ref id="B17-nutrients-13-00154"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escuin</surname><given-names>D.</given-names></name><name><surname>L&#x000f3;pez-Vilar&#x000f3;</surname><given-names>L.</given-names></name><name><surname>Bell</surname><given-names>O.</given-names></name><name><surname>Mora</surname><given-names>J.</given-names></name><name><surname>Moral</surname><given-names>A.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>J.I.</given-names></name><name><surname>Arqueros</surname><given-names>C.</given-names></name><name><surname>Cajal</surname><given-names>T.R.Y.</given-names></name><name><surname>Lerma</surname><given-names>E.</given-names></name><name><surname>Barnadas</surname><given-names>A.</given-names></name></person-group><article-title>MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer</article-title><source>Front. Genet.</source><year>2020</year><volume>11</volume><fpage>562114</fpage><pub-id pub-id-type="doi">10.3389/fgene.2020.562114</pub-id><pub-id pub-id-type="pmid">33343622</pub-id></element-citation></ref><ref id="B18-nutrients-13-00154"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>M.N.</given-names></name><name><surname>Kim</surname><given-names>C.</given-names></name><name><surname>Kang</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>H.-S.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.-H.</given-names></name><name><surname>Shim</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name></person-group><article-title>MiR-657/ATF2 Signaling Pathway Has a Critical Role in Spatholobus suberectus Dunn Extract-Induced Apoptosis in U266 and U937 Cells</article-title><source>Cancers</source><year>2019</year><volume>11</volume><elocation-id>150</elocation-id><pub-id pub-id-type="doi">10.3390/cancers11020150</pub-id></element-citation></ref><ref id="B19-nutrients-13-00154"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.</given-names></name><name><surname>Song</surname><given-names>H.-S.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name></person-group><article-title>Activation of ER Stress-Dependent miR-216b Has a Critical Role in Salvia miltiorrhiza Ethanol-Extract-Induced Apoptosis in U266 and U937 Cells</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>1240</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19041240</pub-id></element-citation></ref><ref id="B20-nutrients-13-00154"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phuah</surname><given-names>N.H.</given-names></name><name><surname>Azmi</surname><given-names>M.N.</given-names></name><name><surname>Awang</surname><given-names>K.</given-names></name><name><surname>Nagoor</surname><given-names>N.H.</given-names></name></person-group><article-title>Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1&#x02019;S-1&#x02019;-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD</article-title><source>Mol. Cells</source><year>2017</year><volume>40</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.14348/molcells.2017.2285</pub-id><pub-id pub-id-type="pmid">28401751</pub-id></element-citation></ref><ref id="B21-nutrients-13-00154"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>S.</given-names></name><name><surname>Choi</surname><given-names>E.</given-names></name><name><surname>Hwang</surname><given-names>C.-H.</given-names></name><name><surname>Jung</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.-H.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name></person-group><article-title>Dietary Compounds for Targeting Prostate Cancer</article-title><source>Nutritients</source><year>2019</year><volume>11</volume><elocation-id>2401</elocation-id><pub-id pub-id-type="doi">10.3390/nu11102401</pub-id></element-citation></ref><ref id="B22-nutrients-13-00154"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>S.W.</given-names></name><name><surname>Lin</surname><given-names>A.W.</given-names></name></person-group><article-title>Apoptosis in cancer</article-title><source>Carcinog.</source><year>2000</year><volume>21</volume><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1093/carcin/21.3.485</pub-id></element-citation></ref><ref id="B23-nutrients-13-00154"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.-Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>W.-G.</given-names></name><name><surname>Lin</surname><given-names>G.-S.</given-names></name></person-group><article-title>Synthesis and In Vitro Anticancer Activity of Novel Dehydroabietic Acid-Based Acylhydrazones</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1087</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22071087</pub-id><?supplied-pmid 28661452?><pub-id pub-id-type="pmid">28661452</pub-id></element-citation></ref><ref id="B24-nutrients-13-00154"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnu</surname><given-names>V.R.</given-names></name><name><surname>Renjith</surname><given-names>R.S.</given-names></name><name><surname>Mukherjee</surname><given-names>A.</given-names></name><name><surname>Anil</surname><given-names>S.R.</given-names></name><name><surname>Sreekumar</surname><given-names>J.</given-names></name><name><surname>Jyothi</surname><given-names>A.N.</given-names></name><name><surname>Alummoottil</surname><given-names>J.N.</given-names></name></person-group><article-title>Comparative Study on the Chemical Structure and In Vitro Antiproliferative Activity of Anthocyanins in Purple Root Tubers and Leaves of Sweet Potato (Ipomoea batatas)</article-title><source>J. Agric. Food Chem.</source><year>2019</year><volume>67</volume><fpage>2467</fpage><lpage>2475</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.8b05473</pub-id><?supplied-pmid 30741542?><pub-id pub-id-type="pmid">30741542</pub-id></element-citation></ref><ref id="B25-nutrients-13-00154"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piboonprai</surname><given-names>K.</given-names></name><name><surname>Khumkhrong</surname><given-names>P.</given-names></name><name><surname>Khongkow</surname><given-names>M.</given-names></name><name><surname>Yata</surname><given-names>T.</given-names></name><name><surname>Ruangrungsi</surname><given-names>N.</given-names></name><name><surname>Chansriniyom</surname><given-names>C.</given-names></name><name><surname>Iempridee</surname><given-names>T.</given-names></name></person-group><article-title>Anticancer activity of arborinine from Glycosmis parva leaf extract in human cervical cancer cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2018</year><volume>500</volume><fpage>866</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.04.175</pub-id><?supplied-pmid 29705700?><pub-id pub-id-type="pmid">29705700</pub-id></element-citation></ref><ref id="B26-nutrients-13-00154"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group><article-title>Therapeutic effects of &#x003b2;-elemene via attenuation of the Wnt/&#x003b2;-catenin signaling pathway in cervical cancer cells</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>17</volume><fpage>4299</fpage><lpage>4306</lpage><pub-id pub-id-type="doi">10.3892/mmr.2018.8455</pub-id><?supplied-pmid 29363722?><pub-id pub-id-type="pmid">29363722</pub-id></element-citation></ref><ref id="B27-nutrients-13-00154"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehana</surname><given-names>D.</given-names></name><name><surname>Mahendiran</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>R.S.</given-names></name><name><surname>Rahiman</surname><given-names>A.K.</given-names></name></person-group><article-title>Evaluation of antioxidant and anticancer activity of copper oxide nanoparticles synthesized using medicinally important plant extracts</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>89</volume><fpage>1067</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.02.101</pub-id><pub-id pub-id-type="pmid">28292015</pub-id></element-citation></ref><ref id="B28-nutrients-13-00154"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and In Vitro and In Vivo Evaluation</article-title><source>J. Biomed. Nanotechnol.</source><year>2017</year><volume>13</volume><fpage>1631</fpage><lpage>1646</lpage><pub-id pub-id-type="doi">10.1166/jbn.2017.2442</pub-id><pub-id pub-id-type="pmid">29490752</pub-id></element-citation></ref><ref id="B29-nutrients-13-00154"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>T.F.</given-names></name><name><surname>Sorbo</surname><given-names>J.M.</given-names></name><name><surname>Souza</surname><given-names>F.D.O.</given-names></name><name><surname>Fernandes</surname><given-names>B.C.</given-names></name><name><surname>Ocampos</surname><given-names>F.M.M.</given-names></name><name><surname>De Oliveira</surname><given-names>D.M.S.</given-names></name><name><surname>Arcaro</surname><given-names>C.A.</given-names></name><name><surname>Assis</surname><given-names>R.P.</given-names></name><name><surname>Barison</surname><given-names>A.</given-names></name><name><surname>Miguel</surname><given-names>O.G.</given-names></name><etal/></person-group><article-title>Emodin, Physcion, and Crude Extract of Rhamnus sphaerosperma var. pubescens Induce Mixed Cell Death, Increase in Oxidative Stress, DNA Damage, and Inhibition of AKT in Cervical and Oral Squamous Carcinoma Cell Lines</article-title><source>Oxidative Med. Cell. Longev.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1155/2018/2390234</pub-id></element-citation></ref><ref id="B30-nutrients-13-00154"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Fa</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name></person-group><article-title>Apoptosis induction of epifriedelinol on human cervical cancer cell line</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2017</year><volume>14</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.21010/ajtcam.v14i4.10</pub-id><pub-id pub-id-type="pmid">28638870</pub-id></element-citation></ref><ref id="B31-nutrients-13-00154"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Harshadha</surname><given-names>K.</given-names></name><name><surname>Dhinesh Kannan</surname><given-names>S.</given-names></name><name><surname>Hari Raj</surname><given-names>K.</given-names></name><name><surname>Jayaprakash</surname><given-names>B.</given-names></name></person-group><article-title>Evaluation of therapeutic potential of eugenol-a natural derivative of Syzygium aromaticum on cervical cancer</article-title><source>APJCP</source><year>2018</year><volume>19</volume><fpage>1977</fpage><pub-id pub-id-type="pmid">30051686</pub-id></element-citation></ref><ref id="B32-nutrients-13-00154"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells</article-title><source>Oncol. Rep.</source><year>2018</year><volume>41</volume><fpage>765</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6864</pub-id><?supplied-pmid 30431140?><pub-id pub-id-type="pmid">30431140</pub-id></element-citation></ref><ref id="B33-nutrients-13-00154"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>C.-Y.</given-names></name><name><surname>Schelz</surname><given-names>Z.</given-names></name><name><surname>T&#x000f3;th</surname><given-names>B.</given-names></name><name><surname>Vasas</surname><given-names>A.</given-names></name><name><surname>Ocsovszki</surname><given-names>I.</given-names></name><name><surname>Chang</surname><given-names>F.-R.</given-names></name><name><surname>Hohmann</surname><given-names>J.</given-names></name><name><surname>Zupk&#x000f3;</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>H.-C.</given-names></name></person-group><article-title>Investigation of natural phenanthrenes and the antiproliferative potential of juncusol in cervical cancer cell lines</article-title><source>Phytomedicine</source><year>2018</year><volume>58</volume><fpage>152770</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.11.030</pub-id><?supplied-pmid 31005716?><pub-id pub-id-type="pmid">31005716</pub-id></element-citation></ref><ref id="B34-nutrients-13-00154"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y.-L.</given-names></name><name><surname>Zhang</surname><given-names>Y.-S.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.-Y.</given-names></name><name><surname>Thakur</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>J.-G.</given-names></name><name><surname>Wei</surname><given-names>Z.-J.</given-names></name></person-group><article-title>Methyl protodioscin from Polygonatum sibiricum inhibits cervical cancer through cell cycle arrest and apoptosis induction</article-title><source>Food Chem. Toxicol.</source><year>2019</year><volume>132</volume><fpage>110655</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110655</pub-id><pub-id pub-id-type="pmid">31271762</pub-id></element-citation></ref><ref id="B35-nutrients-13-00154"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Otaibi</surname><given-names>W.A.</given-names></name><name><surname>Alkhatib</surname><given-names>M.H.</given-names></name><name><surname>Wali</surname><given-names>A.N.</given-names></name></person-group><article-title>Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>106</volume><fpage>946</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.041</pub-id><pub-id pub-id-type="pmid">30119267</pub-id></element-citation></ref><ref id="B36-nutrients-13-00154"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latif</surname><given-names>A.D.</given-names></name><name><surname>Gonda</surname><given-names>T.</given-names></name><name><surname>V&#x000e1;gv&#x000f6;lgyi</surname><given-names>M.</given-names></name><name><surname>K&#x000fa;sz</surname><given-names>N.</given-names></name><name><surname>Kulm&#x000e1;ny</surname><given-names>&#x000c1;.</given-names></name><name><surname>Ocsovszki</surname><given-names>I.</given-names></name><name><surname>Zomborszki</surname><given-names>Z.P.</given-names></name><name><surname>Zupk&#x000f3;</surname><given-names>I.</given-names></name><name><surname>Hunyadi</surname><given-names>A.</given-names></name></person-group><article-title>Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>2184</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20092184</pub-id></element-citation></ref><ref id="B37-nutrients-13-00154"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>F.D.O.</given-names></name><name><surname>Sorbo</surname><given-names>J.M.</given-names></name><name><surname>Regasini</surname><given-names>L.O.</given-names></name><name><surname>Rosa</surname><given-names>J.C.</given-names></name><name><surname>Czernys</surname><given-names>&#x000c9;.D.S.</given-names></name><name><surname>Valente</surname><given-names>V.</given-names></name><name><surname>Moreira</surname><given-names>T.F.</given-names></name><name><surname>Navegante</surname><given-names>G.</given-names></name><name><surname>Fernandes</surname><given-names>B.C.</given-names></name><name><surname>Soares</surname><given-names>C.P.</given-names></name></person-group><article-title>Nitensidine B affects proteins of the glycolytic pathway and induces apoptosis in cervical carcinoma cells immortalized by HPV</article-title><source>Phytomedicine</source><year>2018</year><volume>48</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.05.016</pub-id><?supplied-pmid 30195876?><pub-id pub-id-type="pmid">30195876</pub-id></element-citation></ref><ref id="B38-nutrients-13-00154"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>J.-X.</given-names></name><name><surname>Wang</surname><given-names>X.-Q.</given-names></name><name><surname>Liu</surname><given-names>X.-K.</given-names></name><name><surname>Chen</surname><given-names>X.-X.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>He</surname><given-names>Z.-D.</given-names></name><name><surname>Liu</surname><given-names>D.-Z.</given-names></name><name><surname>Chen</surname><given-names>L.-X.</given-names></name><name><surname>Wang</surname><given-names>L.-W.</given-names></name><etal/></person-group><article-title>Notoginsenoside R7 suppresses cervical cancer via PI3K/PTEN/Akt/mTOR signaling</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>109487</fpage><lpage>109496</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.22721</pub-id><pub-id pub-id-type="pmid">29312623</pub-id></element-citation></ref><ref id="B39-nutrients-13-00154"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Zou</surname><given-names>K.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name></person-group><article-title>Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NF-&#x003ba;B signaling</article-title><source>Oncol. Rep.</source><year>2018</year><volume>40</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6514</pub-id><pub-id pub-id-type="pmid">29989651</pub-id></element-citation></ref><ref id="B40-nutrients-13-00154"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvan</surname><given-names>D.A.</given-names></name><name><surname>Mahendiran</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>R.S.</given-names></name><name><surname>Rahiman</surname><given-names>A.K.</given-names></name></person-group><article-title>Garlic, green tea and turmeric extracts-mediated green synthesis of silver nanoparticles: Phytochemical, antioxidant and in vitro cytotoxicity studies</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2018</year><volume>180</volume><fpage>243</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2018.02.014</pub-id></element-citation></ref><ref id="B41-nutrients-13-00154"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name></person-group><article-title>Alkaloids from Piper nigrum Synergistically Enhanced the Effect of Paclitaxel against Paclitaxel-Resistant Cervical Cancer Cells through the Downregulation of Mcl-1</article-title><source>J. Agric. Food Chem.</source><year>2019</year><volume>67</volume><fpage>5159</fpage><lpage>5168</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.9b01320</pub-id><pub-id pub-id-type="pmid">31006247</pub-id></element-citation></ref><ref id="B42-nutrients-13-00154"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Hao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Deng</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Qin</surname><given-names>J.K.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Cytotoxic Activity and Related Mechanisms of Prenylflavonoids Isolated from Mallotus conspurcatus Croizat</article-title><source>Chem. Biodivers.</source><year>2019</year><volume>16</volume><fpage>e1800465</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201800465</pub-id><?supplied-pmid 30779297?><pub-id pub-id-type="pmid">30779297</pub-id></element-citation></ref><ref id="B43-nutrients-13-00154"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.-L.</given-names></name><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Chen</surname><given-names>C.-M.</given-names></name><name><surname>Cheng</surname><given-names>C.-W.</given-names></name><name><surname>Chen</surname><given-names>P.-N.</given-names></name><name><surname>Ying</surname><given-names>T.-H.</given-names></name><name><surname>Hsieh</surname><given-names>Y.-H.</given-names></name></person-group><article-title>Protodioscin induces apoptosis through ROS-mediated endoplasmic reticulum stress via the JNK/p38 activation pathways in human cervical cancer cells</article-title><source>Cell. Physiol. Biochem.</source><year>2018</year><volume>46</volume><fpage>322</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1159/000488433</pub-id><?supplied-pmid 29590661?><pub-id pub-id-type="pmid">29590661</pub-id></element-citation></ref><ref id="B44-nutrients-13-00154"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>K.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Vanmanen</surname><given-names>J.</given-names></name><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Fata</surname><given-names>J.E.</given-names></name></person-group><article-title>Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis</article-title><source>Front. Oncol.</source><year>2019</year><volume>9</volume><fpage>352</fpage><pub-id pub-id-type="doi">10.3389/fonc.2019.00352</pub-id><?supplied-pmid 31143704?><pub-id pub-id-type="pmid">31143704</pub-id></element-citation></ref><ref id="B45-nutrients-13-00154"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Qu</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>R.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment</article-title><source>Int. J. Nanomed.</source><year>2018</year><volume>13</volume><fpage>7275</fpage><lpage>7287</lpage><pub-id pub-id-type="doi">10.2147/IJN.S182475</pub-id><?supplied-pmid 30510417?><pub-id pub-id-type="pmid">30510417</pub-id></element-citation></ref><ref id="B46-nutrients-13-00154"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Ijaz</surname><given-names>I.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name></person-group><article-title>Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>2105</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22122105</pub-id><?supplied-pmid 29207526?><pub-id pub-id-type="pmid">29207526</pub-id></element-citation></ref><ref id="B47-nutrients-13-00154"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Tsering</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name></person-group><article-title>An Integrated Study on the Antitumor Effect and Mechanism of Triphala Against Gynecological Cancers Based on Network Pharmacological Prediction and In Vitro Experimental Validation</article-title><source>Integr. Cancer Ther.</source><year>2018</year><volume>17</volume><fpage>894</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1177/1534735418774410</pub-id><?supplied-pmid 29742928?><pub-id pub-id-type="pmid">29742928</pub-id></element-citation></ref><ref id="B48-nutrients-13-00154"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phuah</surname><given-names>N.H.</given-names></name><name><surname>Azmi</surname><given-names>M.N.</given-names></name><name><surname>Awang</surname><given-names>K.</given-names></name><name><surname>Nagoor</surname><given-names>N.H.</given-names></name></person-group><article-title>Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1&#x02032;S-1&#x02032;-acetoxychavicol acetate via regulating RSU1</article-title><source>OncoTargets Ther.</source><year>2017</year><volume>10</volume><fpage>1695</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.2147/OTT.S117492</pub-id><?supplied-pmid 28356756?><pub-id pub-id-type="pmid">28356756</pub-id></element-citation></ref><ref id="B49-nutrients-13-00154"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Dehaen</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.-J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Huai</surname><given-names>Q.-Y.</given-names></name></person-group><article-title>Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties</article-title><source>Bioorganic Chem.</source><year>2019</year><volume>88</volume><fpage>102951</fpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2019.102951</pub-id></element-citation></ref><ref id="B50-nutrients-13-00154"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>A.H.</given-names></name><name><surname>Choi</surname><given-names>E.</given-names></name><name><surname>Yoon</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>K.W.</given-names></name><name><surname>Yoo</surname><given-names>S.Y.</given-names></name><name><surname>Cho</surname><given-names>M.C.</given-names></name><name><surname>Yang</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>H.I.</given-names></name><name><surname>Hong</surname><given-names>J.Y.</given-names></name><name><surname>Shin</surname><given-names>J.-S.</given-names></name><etal/></person-group><article-title>Natural products hybrids: 3,5,4&#x02019;-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells</article-title><source>Eur. J. Med. Chem.</source><year>2018</year><volume>161</volume><fpage>559</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2018.10.062</pub-id><pub-id pub-id-type="pmid">30396104</pub-id></element-citation></ref><ref id="B51-nutrients-13-00154"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name></person-group><article-title>A natural product enhances apoptosis via mitochondria/caspase-mediated pathway in HeLa cells</article-title><source>J. Cell. Biochem.</source><year>2019</year><volume>120</volume><fpage>16811</fpage><lpage>16823</lpage><pub-id pub-id-type="doi">10.1002/jcb.28939</pub-id><pub-id pub-id-type="pmid">31099051</pub-id></element-citation></ref><ref id="B52-nutrients-13-00154"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiandalo</surname><given-names>M.</given-names></name><name><surname>Kyprianou</surname><given-names>N.</given-names></name></person-group><article-title>Caspase control: Protagonists of cancer cell apoptosis</article-title><source>Exp. Oncol.</source><year>2012</year><volume>34</volume><fpage>165</fpage><lpage>175</lpage><?supplied-pmid 23070001?><pub-id pub-id-type="pmid">23070001</pub-id></element-citation></ref><ref id="B53-nutrients-13-00154"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M.H.</given-names></name><name><surname>Reynolds</surname><given-names>C.P.</given-names></name></person-group><article-title>Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy</article-title><source>Clin. Cancer Res.</source><year>2009</year><volume>15</volume><fpage>1126</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-0144</pub-id><?supplied-pmid 19228717?><pub-id pub-id-type="pmid">19228717</pub-id></element-citation></ref><ref id="B54-nutrients-13-00154"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>W.K.</given-names></name><name><surname>Gomez-Navarro</surname><given-names>J.</given-names></name><name><surname>Arafat</surname><given-names>W.O.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Mahasreshti</surname><given-names>P.J.</given-names></name><name><surname>Alvarez</surname><given-names>R.D.</given-names></name><name><surname>Barnes</surname><given-names>M.N.</given-names></name><name><surname>Curiel</surname><given-names>D.T.</given-names></name></person-group><article-title>Bax-Induced Apoptosis as a Novel Gene Therapy Approach for Carcinoma of the Cervix</article-title><source>Gynecol. Oncol.</source><year>2001</year><volume>83</volume><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1006/gyno.2001.6403</pub-id><?supplied-pmid 11606099?><pub-id pub-id-type="pmid">11606099</pub-id></element-citation></ref><ref id="B55-nutrients-13-00154"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanepoel</surname><given-names>B.</given-names></name><name><surname>Venables</surname><given-names>L.</given-names></name><name><surname>Octavian-Tudorel</surname><given-names>O.</given-names></name><name><surname>Nitulescu</surname><given-names>G.M.</given-names></name><name><surname>Van De Venter</surname><given-names>M.</given-names></name></person-group><article-title>In Vitro Anti-proliferative Activity and Mechanism of Action of Anemone nemorosa</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>1217</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20051217</pub-id></element-citation></ref><ref id="B56-nutrients-13-00154"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwarka</surname><given-names>D.</given-names></name><name><surname>Thaver</surname><given-names>V.</given-names></name><name><surname>Naidu</surname><given-names>M.</given-names></name><name><surname>Koorbanally</surname><given-names>N.A.</given-names></name><name><surname>Baijnath</surname><given-names>A.H.</given-names></name></person-group><article-title>In vitro chemo-preventative activity of strelitzia nicolai aril extract containing bilirubin</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2017</year><volume>14</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.21010/ajtcam.v14i3.16</pub-id><pub-id pub-id-type="pmid">28480426</pub-id></element-citation></ref><ref id="B57-nutrients-13-00154"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.M.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>Y.K.</given-names></name><name><surname>Choi</surname><given-names>Y.J.</given-names></name><name><surname>Seo</surname><given-names>H.S.</given-names></name><name><surname>Ko</surname><given-names>S.G.</given-names></name></person-group><article-title>SH003-induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>16</volume><fpage>8237</fpage><lpage>8244</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7597</pub-id><pub-id pub-id-type="pmid">28944910</pub-id></element-citation></ref><ref id="B58-nutrients-13-00154"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>K.M.</given-names></name><name><surname>Gomes</surname><given-names>I.N.F.</given-names></name><name><surname>Silva-Oliveira</surname><given-names>R.J.</given-names></name><name><surname>Pinto</surname><given-names>F.E.</given-names></name><name><surname>Oliveira</surname><given-names>B.G.</given-names></name><name><surname>Chagas</surname><given-names>R.C.R.</given-names></name><name><surname>Rom&#x000e3;o</surname><given-names>W.</given-names></name><name><surname>Reis</surname><given-names>R.M.</given-names></name><name><surname>Ribeiro</surname><given-names>R.I.M.D.A.</given-names></name></person-group><article-title>Bauhinia variegata candida Fraction Induces Tumor Cell Death by Activation of Caspase-3, RIP, and TNF-R1 and Inhibits Cell Migration and Invasion In Vitro</article-title><source>BioMed Res. Int.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2018/4702481</pub-id></element-citation></ref><ref id="B59-nutrients-13-00154"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>S.-S.</given-names></name><name><surname>Kim</surname><given-names>S.-M.</given-names></name><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Hong</surname><given-names>J.-M.</given-names></name><name><surname>Lee</surname><given-names>S.G.</given-names></name><name><surname>Youn</surname><given-names>U.J.</given-names></name><name><surname>Han</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>I.C.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name></person-group><article-title>Anticancer activities of ethanol extract from the Antarctic freshwater microalga, Botryidiopsidaceae sp</article-title><source>BMC Complement. Altern. Med.</source><year>2017</year><volume>17</volume><elocation-id>509</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-017-1991-x</pub-id><pub-id pub-id-type="pmid">29191192</pub-id></element-citation></ref><ref id="B60-nutrients-13-00154"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>S.-S.</given-names></name><name><surname>Yang</surname><given-names>E.J.</given-names></name><name><surname>Lee</surname><given-names>S.G.</given-names></name><name><surname>Youn</surname><given-names>U.J.</given-names></name><name><surname>Han</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>I.-C.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name></person-group><article-title>Bioactivities of ethanol extract from the Antarctic freshwater microalga, Chloromonas sp</article-title><source>Int. J. Med Sci.</source><year>2017</year><volume>14</volume><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.7150/ijms.18702</pub-id><pub-id pub-id-type="pmid">28638272</pub-id></element-citation></ref><ref id="B61-nutrients-13-00154"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>R.</given-names></name><name><surname>Rana</surname><given-names>N.K.</given-names></name><name><surname>Koch</surname><given-names>B.</given-names></name></person-group><article-title>Dendrobium chrysanthum ethanolic extract induces apoptosis via p53 up-regulation in HeLa cells and inhibits tumor progression in mice</article-title><source>J. Complement. Integr. Med.</source><year>2017</year><volume>14</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1515/jcim-2016-0070</pub-id></element-citation></ref><ref id="B62-nutrients-13-00154"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J.F.</given-names></name><name><surname>Wei</surname><given-names>P.F.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>Y.P.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>L.X.</given-names></name><name><surname>Wen</surname><given-names>L.P.</given-names></name></person-group><article-title>The Ethyl Acetate Extract of Gynura formosana Kitam. Leaves Inhibited Cervical Cancer Cell Proliferation via Induction of Autophagy</article-title><source>BioMed Res. Int.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2018/4780612</pub-id></element-citation></ref><ref id="B63-nutrients-13-00154"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuriakose</surname><given-names>G.C.</given-names></name><name><surname>M</surname><given-names>D.L.</given-names></name><name><surname>Bp</surname><given-names>A.</given-names></name><name><surname>Rs</surname><given-names>H.K.</given-names></name><name><surname>Th</surname><given-names>A.K.</given-names></name><name><surname>Ananthaswamy</surname><given-names>K.</given-names></name><name><surname>Chelliah</surname><given-names>J.</given-names></name></person-group><article-title>Extract of Penicillium sclerotiorum an endophytic fungus isolated from Cassia fistula L. induces cell cycle arrest leading to apoptosis through mitochondrial membrane depolarization in human cervical cancer cells</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>105</volume><fpage>1062</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.06.094</pub-id><?supplied-pmid 30021342?><pub-id pub-id-type="pmid">30021342</pub-id></element-citation></ref><ref id="B64-nutrients-13-00154"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dan</surname><given-names>V.M.</given-names></name><name><surname>Muralikrishnan</surname><given-names>B.</given-names></name><name><surname>Sanawar</surname><given-names>R.</given-names></name><name><surname>S</surname><given-names>V.J.</given-names></name><name><surname>Burkul</surname><given-names>B.B.</given-names></name><name><surname>Srinivas</surname><given-names>K.P.</given-names></name><name><surname>Lekshmi</surname><given-names>A.</given-names></name><name><surname>Pradeep</surname><given-names>N.S.</given-names></name><name><surname>Dastager</surname><given-names>S.G.</given-names></name><name><surname>Santhakumari</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Streptomyces sp. metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>2810</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-21249-5</pub-id><?supplied-pmid 29434241?><pub-id pub-id-type="pmid">29434241</pub-id></element-citation></ref><ref id="B65-nutrients-13-00154"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>K.T.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Bai</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Wakefield</surname><given-names>M.R.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name></person-group><article-title>Blueberry as a Potential Radiosensitizer for Treating Cervical Cancer</article-title><source>Pathol. Oncol. Res.</source><year>2019</year><volume>25</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/s12253-017-0319-y</pub-id><?supplied-pmid 28963664?><pub-id pub-id-type="pmid">28963664</pub-id></element-citation></ref><ref id="B66-nutrients-13-00154"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Yao</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><collab>Guiling with the Pinellia Pedatisecta (PE) Advisory Group</collab><name><surname>Xu</surname><given-names>C.-J.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Gui</surname><given-names>S.</given-names></name></person-group><article-title>Immune modulation of a lipid-soluble extract of Pinellia pedatisecta Schott in the tumor microenvironment of an HPV + tumor-burdened mouse model</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>225</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.04.037</pub-id><?supplied-pmid 29783020?><pub-id pub-id-type="pmid">29783020</pub-id></element-citation></ref><ref id="B67-nutrients-13-00154"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khazaei</surname><given-names>S.</given-names></name><name><surname>Ramachandran</surname><given-names>V.</given-names></name><name><surname>Hamid</surname><given-names>R.A.</given-names></name><name><surname>Esa</surname><given-names>N.M.</given-names></name><name><surname>Etemad</surname><given-names>A.</given-names></name><name><surname>Moradipoor</surname><given-names>S.</given-names></name><name><surname>Patimah</surname><given-names>I.</given-names></name></person-group><article-title>Flower extract of Allium atroviolaceum triggered apoptosis, activated caspase-3 and down-regulated antiapoptotic Bcl-2 gene in HeLa cancer cell line</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>89</volume><fpage>1216</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.02.082</pub-id><?supplied-pmid 28320088?><pub-id pub-id-type="pmid">28320088</pub-id></element-citation></ref><ref id="B68-nutrients-13-00154"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>T.</given-names></name><name><surname>Sansone</surname><given-names>F.</given-names></name><name><surname>Franceschelli</surname><given-names>S.</given-names></name><name><surname>Del Gaudio</surname><given-names>P.</given-names></name><name><surname>Picerno</surname><given-names>P.</given-names></name><name><surname>Aquino</surname><given-names>R.P.</given-names></name><name><surname>Mencherini</surname><given-names>T.</given-names></name></person-group><article-title>Hazelnut (Corylus avellana L.) Shells Extract: Phenolic Composition, Antioxidant Effect and Cytotoxic Activity on Human Cancer Cell Lines</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>392</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18020392</pub-id></element-citation></ref><ref id="B69-nutrients-13-00154"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannarreddy</surname><given-names>P.</given-names></name><name><surname>Denis</surname><given-names>M.</given-names></name><name><surname>Munireddy</surname><given-names>D.</given-names></name><name><surname>Pandurangan</surname><given-names>R.</given-names></name><name><surname>Thangavelu</surname><given-names>K.P.</given-names></name><name><surname>Venkatesan</surname><given-names>K.</given-names></name></person-group><article-title>Cytotoxic effect of Cyperus rotundus rhizome extract on human cancer cell lines</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>95</volume><fpage>1375</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.09.051</pub-id><pub-id pub-id-type="pmid">28946185</pub-id></element-citation></ref><ref id="B70-nutrients-13-00154"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayarathna</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Kanwar</surname><given-names>J.R.</given-names></name><name><surname>Sasidharan</surname><given-names>S.</given-names></name></person-group><article-title>Standardized Polyalthia longifolia leaf extract (PLME) inhibits cell proliferation and promotes apoptosis: The anti-cancer study with various microscopy methods</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>91</volume><fpage>366</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.04.112</pub-id><pub-id pub-id-type="pmid">28463800</pub-id></element-citation></ref><ref id="B71-nutrients-13-00154"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sul&#x02018;ain</surname><given-names>M.D.</given-names></name><name><surname>Fashihah Zakaria</surname><given-names>M.F.J.</given-names></name></person-group><article-title>Anti-Proliferative Effects of Methanol and Water Extracts of Pyrrosia piloselloides on the Hela Human Cervical Carcinoma Cell Line</article-title><source>APJCP</source><year>2019</year><volume>20</volume><fpage>185</fpage><pub-id pub-id-type="pmid">30678430</pub-id></element-citation></ref><ref id="B72-nutrients-13-00154"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panicker</surname><given-names>N.G.</given-names></name><name><surname>Balhamar</surname><given-names>S.O.M.S.</given-names></name><name><surname>Akhlaq</surname><given-names>S.</given-names></name><name><surname>Qureshi</surname><given-names>M.M.</given-names></name><name><surname>Rizvi</surname><given-names>T.S.</given-names></name><name><surname>Al-Harrasi</surname><given-names>A.</given-names></name><name><surname>Hussain</surname><given-names>J.</given-names></name><name><surname>Mustafa</surname><given-names>F.</given-names></name></person-group><article-title>Identification and Characterization of the Caspase-Mediated Apoptotic Activity of Teucrium mascatense and an Isolated Compound in Human Cancer Cells</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>977</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24050977</pub-id><?supplied-pmid 30861999?><pub-id pub-id-type="pmid">30861999</pub-id></element-citation></ref><ref id="B73-nutrients-13-00154"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>C.J.</given-names></name><name><surname>Ashworth</surname><given-names>A.</given-names></name></person-group><article-title>Targeted therapy for cancer using PARP inhibitors</article-title><source>Curr. Opin. Pharmacol.</source><year>2008</year><volume>8</volume><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2008.06.016</pub-id><?supplied-pmid 18644251?><pub-id pub-id-type="pmid">18644251</pub-id></element-citation></ref><ref id="B74-nutrients-13-00154"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Waxman</surname><given-names>D.J.</given-names></name></person-group><article-title>Combination of antiangiogenesis with chemotherapy for more effective cancer treatment</article-title><source>Mol. Cancer Ther.</source><year>2008</year><volume>7</volume><fpage>3670</fpage><lpage>3684</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-08-0715</pub-id><pub-id pub-id-type="pmid">19074844</pub-id></element-citation></ref><ref id="B75-nutrients-13-00154"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajabi</surname><given-names>M.</given-names></name><name><surname>Mousa</surname><given-names>S.A.</given-names></name></person-group><article-title>The Role of Angiogenesis in Cancer Treatment</article-title><source>Biomediences</source><year>2017</year><volume>5</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines5020034</pub-id><?supplied-pmid 28635679?><pub-id pub-id-type="pmid">28635679</pub-id></element-citation></ref><ref id="B76-nutrients-13-00154"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomao</surname><given-names>S.</given-names></name><name><surname>Tomao</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>L.</given-names></name><name><surname>Zaccarelli</surname><given-names>E.</given-names></name><name><surname>Caruso</surname><given-names>D.</given-names></name><name><surname>Zoratto</surname><given-names>F.</given-names></name><name><surname>Panici</surname><given-names>P.B.</given-names></name><name><surname>Papa</surname><given-names>A.</given-names></name></person-group><article-title>Angiogenesis and antiangiogenic agents in cervical cancer</article-title><source>OncoTargets Ther.</source><year>2014</year><volume>7</volume><fpage>2237</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.2147/OTT.S68286</pub-id><?supplied-pmid 25506227?><pub-id pub-id-type="pmid">25506227</pub-id></element-citation></ref><ref id="B77-nutrients-13-00154"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shivamadhu</surname><given-names>M.C.</given-names></name><name><surname>Srinivas</surname><given-names>B.K.</given-names></name><name><surname>Jayarama</surname><given-names>S.</given-names></name><name><surname>Chandrashekaraiah</surname><given-names>S.A.</given-names></name></person-group><article-title>Anti-cancer and anti-angiogenic effects of partially purified lectin from Praecitrullus fistulosus fruit on in vitro and in vivo model</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>96</volume><fpage>1299</fpage><lpage>1309</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.11.082</pub-id><pub-id pub-id-type="pmid">29174033</pub-id></element-citation></ref><ref id="B78-nutrients-13-00154"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifaddinipour</surname><given-names>M.</given-names></name><name><surname>Farghadani</surname><given-names>R.</given-names></name><name><surname>Namvar</surname><given-names>F.</given-names></name><name><surname>Bin Mohamad</surname><given-names>J.</given-names></name><name><surname>Kadir</surname><given-names>H.A.</given-names></name></person-group><article-title>Cytotoxic Effects and Anti-Angiogenesis Potential of Pistachio (Pistacia vera L.) Hulls against MCF-7 Human Breast Cancer Cells</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>110</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23010110</pub-id></element-citation></ref><ref id="B79-nutrients-13-00154"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foda</surname><given-names>H.D.</given-names></name><name><surname>Zucker</surname><given-names>S.</given-names></name></person-group><article-title>Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis</article-title><source>Drug Discov. Today</source><year>2001</year><volume>6</volume><fpage>478</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(01)01752-4</pub-id><pub-id pub-id-type="pmid">11344033</pub-id></element-citation></ref><ref id="B80-nutrients-13-00154"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>G.F.</given-names></name></person-group><article-title>Why does cancer therapy lack effective anti-metastasis drugs?</article-title><source>Cancer Lett.</source><year>2013</year><volume>328</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2012.09.025</pub-id><pub-id pub-id-type="pmid">23059758</pub-id></element-citation></ref><ref id="B81-nutrients-13-00154"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanvorachote</surname><given-names>P.</given-names></name><name><surname>Chamni</surname><given-names>S.</given-names></name><name><surname>Ninsontia</surname><given-names>C.</given-names></name><name><surname>Phiboonchaiyanan</surname><given-names>P.P.</given-names></name></person-group><article-title>Potential Anti-metastasis Natural Compounds for Lung Cancer</article-title><source>Anticancer Res.</source><year>2016</year><volume>36</volume><fpage>5707</fpage><lpage>5718</lpage><pub-id pub-id-type="doi">10.21873/anticanres.11154</pub-id><pub-id pub-id-type="pmid">27793892</pub-id></element-citation></ref><ref id="B82-nutrients-13-00154"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Nie</surname><given-names>C.</given-names></name></person-group><article-title>Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF-&#x003b2;1-mediated PI3K and MAPK pathways</article-title><source>Oncol. Rep.</source><year>2019</year><volume>41</volume><fpage>2975</fpage><lpage>2986</lpage><pub-id pub-id-type="doi">10.3892/or.2019.7062</pub-id><?supplied-pmid 30896841?><pub-id pub-id-type="pmid">30896841</pub-id></element-citation></ref><ref id="B83-nutrients-13-00154"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.-Q.</given-names></name><name><surname>Lu</surname><given-names>J.-L.</given-names></name><name><surname>Liang</surname><given-names>Y.-R.</given-names></name><name><surname>Li</surname><given-names>Q.-S.</given-names></name></person-group><article-title>Suppressive Effects of EGCG on Cervical Cancer</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2334</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092334</pub-id><?supplied-pmid 30213130?><pub-id pub-id-type="pmid">30213130</pub-id></element-citation></ref><ref id="B84-nutrients-13-00154"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>C.-Y.</given-names></name><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Chiou</surname><given-names>H.-L.</given-names></name><name><surname>Lin</surname><given-names>C.-L.</given-names></name><name><surname>Chen</surname><given-names>P.-N.</given-names></name><name><surname>Lin</surname><given-names>M.-T.</given-names></name><name><surname>Hsieh</surname><given-names>Y.-H.</given-names></name><name><surname>Chou</surname><given-names>M.-C.</given-names></name></person-group><article-title>Praeruptorin-b inhibits 12-o-tetradecanoylphorbol-13-acetate-induced cell invasion by targeting akt/nf-kappab via matrix metalloproteinase-2/-9 expression in human cervical cancer cells</article-title><source>Cell Physiol. Biochem.</source><year>2019</year><volume>52</volume><fpage>1255</fpage><lpage>1266</lpage><?supplied-pmid 31026389?><pub-id pub-id-type="pmid">31026389</pub-id></element-citation></ref><ref id="B85-nutrients-13-00154"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.-Y.</given-names></name><name><surname>Yang</surname><given-names>S.-F.</given-names></name><name><surname>Wang</surname><given-names>P.-H.</given-names></name><name><surname>Su</surname><given-names>C.-W.</given-names></name><name><surname>Hsu</surname><given-names>H.-F.</given-names></name><name><surname>Tsai</surname><given-names>H.-T.</given-names></name><name><surname>Hsiao</surname><given-names>Y.-H.</given-names></name></person-group><article-title>Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein-9 and MAPK pathway</article-title><source>Environ. Toxicol.</source><year>2019</year><volume>34</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1002/tox.22657</pub-id><pub-id pub-id-type="pmid">30259628</pub-id></element-citation></ref><ref id="B86-nutrients-13-00154"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onder</surname><given-names>T.T.</given-names></name><name><surname>Gupta</surname><given-names>P.B.</given-names></name><name><surname>Mani</surname><given-names>S.A.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Lander</surname><given-names>E.S.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>3645</fpage><lpage>3654</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2938</pub-id><pub-id pub-id-type="pmid">18483246</pub-id></element-citation></ref><ref id="B87-nutrients-13-00154"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasan</surname><given-names>N.</given-names></name><name><surname>Baselga</surname><given-names>J.</given-names></name><name><surname>Hyman</surname><given-names>D.M.</given-names></name></person-group><article-title>A view on drug resistance in cancer</article-title><source>Nat. Cell Biol.</source><year>2019</year><volume>575</volume><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1730-1</pub-id></element-citation></ref><ref id="B88-nutrients-13-00154"><label>88.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gillet</surname><given-names>J.-P.</given-names></name><name><surname>Gottesman</surname><given-names>M.M.</given-names></name></person-group><article-title>Mechanisms of Multidrug Resistance in Cancer</article-title><source>cryoEM</source><publisher-name>Springer Science and Business Media LLC</publisher-name><publisher-loc>Berlin, Germany</publisher-loc><year>2010</year><volume>Volume 596</volume><fpage>47</fpage><lpage>76</lpage></element-citation></ref><ref id="B89-nutrients-13-00154"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faustino</surname><given-names>C.</given-names></name><name><surname>Neto</surname><given-names>&#x000cd;.</given-names></name><name><surname>Fonte</surname><given-names>P.</given-names></name><name><surname>Macedo</surname><given-names>A.</given-names></name></person-group><article-title>Cytotoxicity and Chemotherapeutic Potential of Natural Rosin Abietane Diterpenoids and their Synthetic Derivatives</article-title><source>Curr. Pharm. Des.</source><year>2018</year><volume>24</volume><fpage>4362</fpage><lpage>4375</lpage><pub-id pub-id-type="doi">10.2174/1381612825666190112162817</pub-id><pub-id pub-id-type="pmid">30648502</pub-id></element-citation></ref><ref id="B90-nutrients-13-00154"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levrier</surname><given-names>C.</given-names></name><name><surname>Rockstroh</surname><given-names>A.</given-names></name><name><surname>Gabrielli</surname><given-names>B.</given-names></name><name><surname>Kavallaris</surname><given-names>M.</given-names></name><name><surname>Lehman</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Sadowski</surname><given-names>M.C.</given-names></name><name><surname>Nelson</surname><given-names>C.</given-names></name></person-group><article-title>Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells</article-title><source>Cell Cycle</source><year>2018</year><volume>17</volume><fpage>652</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1080/15384101.2017.1356512</pub-id><pub-id pub-id-type="pmid">28749250</pub-id></element-citation></ref><ref id="B91-nutrients-13-00154"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levrier</surname><given-names>C.</given-names></name><name><surname>Sadowski</surname><given-names>M.C.</given-names></name><name><surname>Rockstroh</surname><given-names>A.</given-names></name><name><surname>Gabrielli</surname><given-names>B.</given-names></name><name><surname>Kavallaris</surname><given-names>M.</given-names></name><name><surname>Lehman</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Nelson</surname><given-names>C.</given-names></name></person-group><article-title>6&#x003b1;-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells</article-title><source>Mol. Cancer Ther.</source><year>2016</year><volume>16</volume><fpage>3</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-16-0325</pub-id><pub-id pub-id-type="pmid">27760837</pub-id></element-citation></ref><ref id="B92-nutrients-13-00154"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>C.S.</given-names></name><name><surname>Yap</surname><given-names>S.H.</given-names></name><name><surname>Phuah</surname><given-names>N.H.</given-names></name><name><surname>In</surname><given-names>L.L.</given-names></name><name><surname>Nagoor</surname><given-names>N.H.</given-names></name></person-group><article-title>MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells</article-title><source>Lung Cancer</source><year>2014</year><volume>83</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.lungcan.2013.11.024</pub-id><pub-id pub-id-type="pmid">24360396</pub-id></element-citation></ref><ref id="B93-nutrients-13-00154"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Leva</surname><given-names>G.</given-names></name><name><surname>Croce</surname><given-names>C.M.</given-names></name></person-group><article-title>miRNA profiling of cancer</article-title><source>Curr. Opin. Genet. Dev.</source><year>2013</year><volume>23</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2013.01.004</pub-id><?supplied-pmid 23465882?><pub-id pub-id-type="pmid">23465882</pub-id></element-citation></ref><ref id="B94-nutrients-13-00154"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhan</surname><given-names>R.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name></person-group><article-title>Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3&#x02032; untranslated region</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>2302</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.34</pub-id><?supplied-pmid 20190813?><pub-id pub-id-type="pmid">20190813</pub-id></element-citation></ref><ref id="B95-nutrients-13-00154"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K.B.</given-names></name></person-group><article-title>MicroRNA (miRNA) in cancer</article-title><source>Cancer Cell Int.</source><year>2015</year><volume>15</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/s12935-015-0185-1</pub-id><?supplied-pmid 25960691?><pub-id pub-id-type="pmid">25678856</pub-id></element-citation></ref><ref id="B96-nutrients-13-00154"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Moura</surname><given-names>M.D.</given-names></name><name><surname>de Se Silva</surname><given-names>J.</given-names></name><name><surname>de Oliveira</surname><given-names>R.A.G.</given-names></name><name><surname>de Diniz</surname><given-names>M.</given-names></name><name><surname>Barbosa-Filho</surname><given-names>J.M.</given-names></name></person-group><article-title>Natural products reported as potential inhibitors of uterine cervical neoplasia</article-title><source>Acta Farm. Bonaer.</source><year>2002</year><volume>21</volume><fpage>67</fpage><lpage>74</lpage></element-citation></ref><ref id="B97-nutrients-13-00154"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AL</surname><given-names>A.O.</given-names></name></person-group><article-title>Dietary supplements as a treatment for cervical cancer: A systematic review</article-title><source>Nutr. Hosp.</source><year>2013</year><volume>28</volume><fpage>1770</fpage><lpage>1780</lpage><pub-id pub-id-type="pmid">24506350</pub-id></element-citation></ref><ref id="B98-nutrients-13-00154"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>Y.-P.</given-names></name><name><surname>Han</surname><given-names>T.</given-names></name><name><surname>Qin</surname><given-names>L.-P.</given-names></name></person-group><article-title>Plants and cervical cancer: An overview</article-title><source>Expert Opin. Investig. Drugs</source><year>2013</year><volume>22</volume><fpage>1133</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1517/13543784.2013.811486</pub-id></element-citation></ref><ref id="B99-nutrients-13-00154"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>M.</given-names></name><name><surname>Mukherjee</surname><given-names>A.</given-names></name><name><surname>Sarkar</surname><given-names>R.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Biswas</surname><given-names>J.</given-names></name></person-group><article-title>In Search of Natural Remediation for Cervical Cancer</article-title><source>Anti-Cancer Agents Med. Chem.</source><year>2014</year><volume>15</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.2174/1871520614666140722084154</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-13-00154-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structures of compounds derived from natural products inducing apoptosis.</p></caption><graphic xlink:href="nutrients-13-00154-g001"/></fig><fig id="nutrients-13-00154-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structures of compounds derived from natural products inhibiting metastasis.</p></caption><graphic xlink:href="nutrients-13-00154-g002"/></fig><fig id="nutrients-13-00154-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Schematic diagram of drugs resistance signal pathways regulated by natural products in cervical cancer.</p></caption><graphic xlink:href="nutrients-13-00154-g003"/></fig><fig id="nutrients-13-00154-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structures of compounds derived from natural products sensitizing drug resistance.</p></caption><graphic xlink:href="nutrients-13-00154-g004"/></fig><fig id="nutrients-13-00154-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Schematic diagram of miRNAs regulated by natural products in cervical cancer.</p></caption><graphic xlink:href="nutrients-13-00154-g005"/></fig><table-wrap id="nutrients-13-00154-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t001_Table 1</object-id><label>Table 1</label><caption><p>Apoptosis inducing natural products-compounds.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose; Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acylhydrazone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.21 &#x000b5;M; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cancer activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-nutrients-13-00154" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anthocyanins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root tubers and leaves of <italic>Ipomoea batatas</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100, 200 &#x000b5;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis, cell cycle arrest </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;CFP/YFP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-nutrients-13-00154" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arborinine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glycosmis parva</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">110 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of migration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -7<break/>&#x02193;Bcl2-L1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-nutrients-13-00154" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-elemene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Curcuma zedoaria</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30, 40, 50 &#x003bc;g/mL;<break/>24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of proliferation and migration<break/>Induction of cell cycle arrest and apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;p15, p53, Bax<break/>&#x02193;cyclin D1, Bcl-2, MMP-2, -9,<break/>&#x003b2;-catenin, TCF7, c-Myc</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-nutrients-13-00154" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Copper oxide nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Azadirachta indica, Hibiscus rosa-sinensis, Murraya koenigii, Moringa oleifera, Tamarindus indica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2, 5, 10, 25, 50, 100 &#x003bc;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of oxidative stress<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-nutrients-13-00154" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Curcuma longa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa,<break/>C57BL/6, BALB/c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 2 &#x003bc;g/mL; 48 h<break/>In vivo: 25 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;p53, cytochrome c, PARP,<break/>caspase-3, -7, -9<break/>&#x02193;Bcl-2, NF-&#x003ba;B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-nutrients-13-00154" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Emodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rhamnus sphaerosperma</italic> var. <italic>pubescens</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, C33A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.3, 92.8, 185 &#x003bc;g/mL;<break/>6, 12, 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of, apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;NO-, O<sub>2</sub>-, HOCl/OCl-, p-Akt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epifriedelinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aster tataricus</italic>,<break/><italic>Vitex peduncularis</italic> Wall.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50, 100, 250, 500, 1000 &#x003bc;g/mL; 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -8, -9<break/>&#x02193;Bcl-2, -xL, survivin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-nutrients-13-00154" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Syzygium aromaticum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5, 25 &#x000b5;M; 24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, PARP, caspase-3, ROS<break/>&#x02193;Bcl-2, XIAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-nutrients-13-00154" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Icaritin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Epimedium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa: 12.5, 25 &#x000b5;M;<break/>24, 48, 72 h<break/>SiHa: 17, 34 &#x000b5;M;<break/>24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;ROS, Bax, c-caspase-3, -9<break/>&#x02193;Bcl-2, XIAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-nutrients-13-00154" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Juncusol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Juncus inflexu</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1, 3, 10, 30 &#x000b5;M;<break/>24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -8, -9<break/>&#x02193;EGFR, tubulin polymerization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-nutrients-13-00154" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyl protodioscin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhizoma of <italic>Polygonatum sibiricum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.31, 40, 49 &#x000b5;M; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; ROS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-nutrients-13-00154" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitomycin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ginger, Frankincense</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-nutrients-13-00154" ref-type="bibr">35</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin oxime</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HeLa, SiHa</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HeLa: 12, 24 &#x000b5;M; 24 h<break/>SiHa: 18, 36 &#x000b5;M; 24 h</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x02191;caspase-3</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B36-nutrients-13-00154" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin oxime ether</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitensidine B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves of <italic>Pterogyne nitens</italic> Tul.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV16, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30, 60, 120 &#x000b5;M;<break/>6, 12, 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -7<break/>&#x02193;aldolase A, alpha-enolase, pyruvate kinase, glyceraldehyde 3-p-dehydrogenase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-nutrients-13-00154" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Notoginsenoside R7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Panax notoginseng</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa,<break/>BALB/c</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 5, 10, 20, 40 &#x003bc;M;<break/>24, 36, 48 h<break/>In vivo: 5, 10 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, p-PTEN, Akt<break/>&#x02193;Bcl-2, -xL, caspase-3, -9, raptor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-nutrients-13-00154" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osthole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cnidiummonnieri</italic> (L.) Cusson</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa,<break/>C-33A, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40, 80, 120, 160, 200, 240 &#x000b5;M; 24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, c-caspase-3, -9 proteins,<break/>E-cadherin, H2AX<break/>&#x02193;Bcl-2, MMP-2, -9, &#x003b2;-catenin, vimentin, N-cadherin, IKK&#x003b1;,<break/>p-IKK&#x003b1;, p65, p-p65, p50, NF-&#x003ba;B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-nutrients-13-00154" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Physcion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rhamnus sphaerosperma</italic> var. <italic>pubescens</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, C33A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.8, 87.5, 175 &#x003bc;g/mL;<break/>6, 12, 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;HOCl/OCl-, p-Akt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phyto-synthesis of silver nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garlic, Green tea, Turmeric</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2, 5, 10, 25, 50, 100 &#x003bc;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;free radical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-nutrients-13-00154" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Piperine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper nigrum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, PTX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 &#x000b5;M; 6, 24, 72 h<break/>with paclitaxel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, Bcl-2, c-PARP, caspase-3<break/>&#x02193;p-Akt, Mcl-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-nutrients-13-00154" ref-type="bibr">41</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prenylflavonoids C1</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Mallotus conspurcatus</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 &#x003bc;M; 24 h</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Induction of apoptosis</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x02191;EGFP, ROS, Bcl-2, cytochrome c, Apaf-1, caspase-3, -9<break/>&#x02193;c-Myc, hTERT</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B42-nutrients-13-00154" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prenylflavonoids C5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#x003bc;M; 24 h</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protodioscin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dioscoreae rhizome</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, C33A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 &#x003bc;M; 24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and mitochondrial dysfunction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;JNK, p38, PERK, ATF4, Bax, caspase-3, -8, -9, PARP<break/>&#x02193;Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-nutrients-13-00154" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pterostilbene</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HPV E6, TC1,<break/>C57Bl/6</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro: 30 &#x000b5;M; 48 h<break/>In vivo: 1 mM; 5 days</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Induction of cell cycle arrest</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x02191;caspase-3<break/>&#x02193;PCNA, VEGF</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B44-nutrients-13-00154" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tf-CT-ME</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tripterygium wilfordii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5, 1, 2 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of cell cycle arrest and apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;c-caspase-3<break/>&#x02193;Bcl-2/Bax</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-nutrients-13-00154" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10, 20, 40 &#x003bc;M;<break/>24, 36, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of migration and invasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, E-cadherin<break/>&#x02193;Bcl-2, Twist1, vimentin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triphala</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Terminalia chebula</italic> Retz., <italic>Terminalia bellerica</italic> (Gaertn) Roxb., <italic>Phyllanthus emblica</italic> Linn.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25-150 &#x003bc;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;ERK, p53<break/>&#x02193;c-Myc, cyclin D1, p-Akt,<break/>p-NF-&#x003ba;B, p56, p-p44/42, MAPK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-nutrients-13-00154" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02032;S-1&#x02032;-acetoxychavicol acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Alpinia conchigera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CaSki, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20, 30 &#x003bc;M; 6, 12, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;RSU1, GAPDH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-nutrients-13-00154" ref-type="bibr">48</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2D of oleanolic acid and glycyrrhetinic acid</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Ligustri Lucidi Fructus, Glycyrrhiza uralensis</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2, 4 &#x000b5;M; 24, 48 h</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x02191;ROS</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B49-nutrients-13-00154" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3O of oleanolic acid and glycyrrhetinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1, 2 &#x003bc;M; 48 h</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Etc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,5,4&#x02032;-trimethoxystilbene</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">HeLa</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">10 &#x000b5;M; 48 h</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Induction of apoptosis</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B50-nutrients-13-00154" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,6,7-trimethoxyflavone</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02032;-<italic>epi</italic>-SPA-6952A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Streptomyces diastatochromogenes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2, 4, 8, 16 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax/Bcl-2, cytochrome c, caspase-3, -9, c-PARP, p53<break/>&#x02193;MMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-nutrients-13-00154" ref-type="bibr">51</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Cyan fluorescent protein (CFP); yellow fluorescent protein (YFP); Bcl-2-like1 (Bcl2-L1); Bcl-2 associated X protein (Bax); B-cell lymphoma 2 (Bcl-2); matrix metalloproteinase (MMP); transcription factor (TCF); cellular myelocytomatosis oncogene (c-Myc); cytochrome complex (cytochrome c); poly (ADP-ribose) polymerase (PARP); nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x003ba;B); phospho-Akt (p-Akt); B-cell lymphoma-extra large (Bcl-xL); reactive oxygen species (ROS); x-linked inhibitor of apoptosis protein (XIAP); cleaved caspase (c-caspase); epidermal growth factor receptor (EGFR); 3-phosphate-dehydrogenase (3-p-dehydrogenase); phospho-phosphatase and tensin homolog (p-PTEN); epithelial cadherin (E-cadherin); H2A histone family member X (H2AX); neural cadherin (N-cadherin); inhibitor of NF-&#x003ba;B kinase &#x003b1; (IKK&#x003b1;); phospho- IKK&#x003b1; (p-IKK&#x003b1;); phospho-p65 (p-p65); cleaved PARP (c-PARP); myeloid cell leukemia sequence 1 (Mcl-1); enhanced green fluorescent protein (EGFP); apoptotic protease activating factor 1 (Apaf-1); human telomerase reverse transcriptase (hTERT); c-Jun N-terminal kinases (JNK); protein kinase RNA-like endoplasmic reticulum kinase (PERK); activating transcription factor 4 (ATF4); proliferating cell nuclear antigen (PCNA); vascular endothelial growth factor (VEGF); transferrin-modified microemulsion carrying coix seed oil and tripterine (Tf-CT-ME); extracellular signal-regulated kinases (ERK); phospho- NF-&#x003ba;B (p-NF-&#x003ba;B); phospho-p44 (p-p44); mitogen-activated protein kinase (MAPK); Ras suppressor protein 1 (RSU1); glyceraldehyde 3-phosphate dehydrogenase (GAPDH).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00154-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t002_Table 2</object-id><label>Table 2</label><caption><p>Apoptosis inducing natural products-extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose; Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Anemone nemorosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.33 &#x000b1; 2.480 &#x003bc;g/mL;<break/>24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;PS translocation, c-caspase-3, -8, ROS (24 h)<break/>&#x02193;MMP, ROS (48 h)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-nutrients-13-00154" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aril extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Strelitzia nicolai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250 &#x003bc;g/mL; 24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of oxidative stress<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-nutrients-13-00154" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Astragalus membranaceus</italic>,<break/><italic>Angelica gigas</italic>,<break/><italic>Trichosanthes kirilowii</italic> Maximowicz.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100, 200, 400 &#x003bc;g/mL;<break/>24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest<break/>Inhibition of cell viability</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;c-caspase-3, -8, PARP-1<break/>&#x02193;Bax, cyclin D, CDK2, CDK4, CDK6, p27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-nutrients-13-00154" ref-type="bibr">57</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bauhinia variegate candida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell viability and migration<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;c-caspase-3, -8, RIP, TNF-R1<break/>&#x02193;MMP-2, MMP-9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-nutrients-13-00154" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Botryidiopsidaceae</italic> species</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.25, 12.5, 25, 50 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of oxidative stress and migration<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;p53, c-caspase-3<break/>&#x02193;Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-nutrients-13-00154" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Chloromonas</italic> species</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5, 25 &#x003bc;g/mL; 24, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of oxidative stress<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;c-caspase-3, p53<break/>&#x02193;Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-nutrients-13-00154" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrobium chrysanthum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa,<break/>Swiss albino mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 450 &#x003bc;g/mL; 24 h<break/>In vivo: 50, 100 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, p53<break/>&#x02193;Bcl-2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-nutrients-13-00154" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rhamnus sphaerosperma</italic> var. <italic>pubescens</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, C33A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25, 50, 100 &#x003bc;g/mL;<break/>6, 12, 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193;HOCl/OCl-, p-Akt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-nutrients-13-00154" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Gynura formosana</italic> Kitam.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 &#x003bc;g/mL; 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; LC3-II/LC3-I,<break/>&#x02193;P62/GAPDH, MCM7/GAPDH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-nutrients-13-00154" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Penicillium sclerotiorum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5, 25, 50 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, p53, Apaf-1<break/>&#x02193;Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-nutrients-13-00154" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces</italic> species</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20, 40, 60 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and autophagy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -9, Bax, LC3-&#x02161;<break/>&#x02193;PARP, LC3-&#x02160;, Beclin1, p62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-nutrients-13-00154" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blueberry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg/mL; 24 h<break/>with 4 Gy radiotherapy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhancement of radiotherapy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;p53<break/>&#x02193;cyclin D, E, p21, survivin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-nutrients-13-00154" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipid-soluble extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pinellia pedatisecta</italic> Schott.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV<sup>+</sup>TC-1,<break/>C57BL/6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 500 &#x003bc;g/mL;<break/>72, 120 h<break/>In vivo: 10, 20 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of cell cycle arrest and apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; &#x003b2;-catenin, c-Myc, cyclin D1, PPAR1<break/>&#x02193;Th2, Th17 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Allium atroviolaceum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20, 40, 60, 80, 100 &#x003bc;g/mL;<break/>24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of cell cycle arrest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3, -5, -9<break/>&#x02193;Bcl-2, CDK1, p53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-nutrients-13-00154" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Corylus avellane</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250, 500 &#x003bc;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of oxidative stress<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;caspase-3<break/>&#x02193;PARP-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-nutrients-13-00154" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cyperus rotundus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25, 50, 100 &#x003bc;g/mL;<break/>24, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-nutrients-13-00154" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Polyalthia longifolia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 &#x003bc;g/mL; 6, 12, 24, 36 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;Bax, BAD, caspase-3, p21, p53<break/>&#x02193;Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-nutrients-13-00154" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pyrrosia piloselloides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.25 &#x003bc;g/mL; 24, 48, 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-nutrients-13-00154" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Teucrium mascatense</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25, 50, 125, 250 &#x003bc;g/mL; 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191;c-caspase-7, -8, -9, PARP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-nutrients-13-00154" ref-type="bibr">72</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Phosphatidylserine (PS); cyclin-dependant kinase (CDK); receptor-interacting protein (RIP); tumor necrosis factor receptor 1 (TNF-R1); light chain (LC); minichromosome maintenance protein complex (MCM); peroxisome proliferator-activated receptor 1 (PPAR1); T helper cell (Th); Bcl-2-associated death promoter (BAD).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00154-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t003_Table 3</object-id><label>Table 3</label><caption><p>Angiogenesis inhibiting natural products.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound/<break/>Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose; Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruit</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PfLP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Praecitrullus fistulosus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa<break/>Swiss Albino mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 50 &#x000b5;g/mL; 24 h<break/>In vivo: 10 mg/kg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of angiogenesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; MMP-2, -9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-nutrients-13-00154" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Purified flaxseed hydrolysate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.4 &#x000b5;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of angiogenesis and metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; caspase-3<break/>&#x02193; MMP-2, VEGF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B15-nutrients-13-00154" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Penicillium sclerotiorum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.75 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of cell cycle arrest and apoptosis<break/>Inhibition of angiogenesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; Bax, p53, Apaf-1<break/>&#x02193; Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-nutrients-13-00154" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pistacia vera</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81.17 &#x000b1; 2.87 &#x000b5;g/mL; 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of angiogenesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> &#x02193; TNF, Bcl-2, IAP, TRAF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-nutrients-13-00154" ref-type="bibr">78</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><italic>Praecitrullus fistulosus</italic> lectin protein (PfLP); inhibitor of apoptosis protein (IAP); TNF receptor-associated factor (TRAF).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00154-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t004_Table 4</object-id><label>Table 4</label><caption><p>Metastasis inhibiting natural products.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound/<break/>Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose; Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Astragaloside IV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radix Astragali</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">200 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; E-cadherin<break/>&#x02193; p38, PI3K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-nutrients-13-00154" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epigallocatechingallate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green tea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 &#x000b5;g/mL; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell metastasis and proliferation<break/>Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; MMP-2, -9, VEGF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-nutrients-13-00154" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Praeruptorin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Peucedanum praeruptorum</italic> Dunn.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40, 60 &#x000b5;M; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; NF-&#x003ba;B, MMP-2, -9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-nutrients-13-00154" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CaSki, HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#x000b5;M; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis, migration and invasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; E-cadherin<break/>&#x02193; Twist1, Zeb1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bauhinia variegata candida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell viability, migration and invasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; MMP-2, -9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-nutrients-13-00154" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Terminalia catappa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa, SiHa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25, 50, 75 &#x000b5;g/mL; 24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; MMP-9, ERK1/2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-nutrients-13-00154" ref-type="bibr">85</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Phosphoinositide 3-kinase (PI3K); Zinc finger E-box-binding homeobox 1 (Zeb1).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00154-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t005_Table 5</object-id><label>Table 5</label><caption><p>Drug resistance sensitizing natural products.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound/Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose; Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rosin abietane diterpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pine rosin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08 &#x000b1; 0.12 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; caspase-3, Bax<break/>&#x02193; Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-nutrients-13-00154" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thalicthuberine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hernandia albiflora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 &#x000b5;M; 72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02193; tubulin polymers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-nutrients-13-00154" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5, 10 &#x000b5;M; 24, 36 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; E-cadherin<break/>&#x02193; Twist1, Zeb1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-nutrients-13-00154" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6&#x003b1;-acetoxyanopterine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Anopterus macleayanus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2, 11.6 nM; 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; caspase-3, -8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-nutrients-13-00154" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipid-soluble extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pinellia pedatisecta</italic> Schott.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CaSki, HeLa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5000 &#x000b5;g/mL; 3 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; P53<break/>&#x02193; ERK, Bcl-2, PCNA, HPV E6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-nutrients-13-00154" ref-type="bibr">66</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Human papillomavirus E6 (HPV E6).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-13-00154-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-13-00154-t006_Table 6</object-id><label>Table 6</label><caption><p>MicroRNA regulating natural products.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound/Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line/<break/>Animal Model </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose/Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Efficacy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02032;S-1&#x02032;-acetoxychavicol acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Alpinia conchigera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20, 30 &#x000b5;M; 6, 12 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; SMAD4<break/>&#x02193; miR-210 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-nutrients-13-00154" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02032;S-1&#x02032;-acetoxychavicol acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Alpinia conchigera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SiHa, CaSki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20, 30 &#x000b5;M; 6, 12, 48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis<break/>Inhibition of proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02191; caspase-3, -8<break/>&#x02193; miR-629 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-nutrients-13-00154" ref-type="bibr">48</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Mothers against decapentaplegic homolog 4 (SMAD4).</p></fn></table-wrap-foot></table-wrap></floats-group></article>